Edgar Filing: HCP, INC.

Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

For the quarterly period ended June 30, 2013.

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number 001-08895

HCP, INC.

(Exact name of registrant as specified in its charter)

Maryland		33-0091377
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

3760 Kilroy Airport Way, Suite 300
Long Beach, CA 90806
(Address of principal executive offices)

(562) 733-5100
(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or such shorter period that the registrant was required to submit and post such files). YES x NO o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer x		Accelerated Filer o

Non-accelerated Filer o		Smaller Reporting Company o
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) YES o NO x

As of July 25, 2013, there were 455,098,236 shares of the registrant’s $1.00 par value common stock outstanding.

Table of Contents

HCP, INC.

INDEX

	PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements:

	Condensed Consolidated Balance Sheets	3

	Condensed Consolidated Statements of Income	4

	Condensed Consolidated Statements of Comprehensive Income	5

	Condensed Consolidated Statements of Equity	6

	Condensed Consolidated Statements of Cash Flows	7

	Notes to the Condensed Consolidated Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	43

Item 4.	Controls and Procedures	44

	PART II. OTHER INFORMATION

Item 1A.	Risk Factors	45

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45

Item 6.	Exhibits	46

Signatures		47

Table of Contents

HCP, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share data)

(Unaudited)

	June 30,			December 31,
	2013			2012
ASSETS
Real estate:
Buildings and improvements	$	10,692,628		$	10,522,399
Development costs and construction in progress	221,907			236,864
Land	1,852,768			1,847,928
Accumulated depreciation and amortization	(1,905,879		)	(1,731,742		)
Net real estate	10,861,424			10,875,449

Net investment in direct financing leases	6,958,129			6,881,393
Loans receivable, net	555,791			276,030
Investments in and advances to unconsolidated joint ventures	208,878			212,213
Accounts receivable, net of allowance of $2,058 and $1,668, respectively	33,270			34,150
Cash and cash equivalents	53,114			247,673
Restricted cash	44,953			37,848
Intangible assets, net	518,982			552,701
Real estate held for sale, net	6,936			9,578
Other assets, net	810,316			788,520
Total assets(1)	$	20,051,793		$	19,915,555
LIABILITIES AND EQUITY
Bank line of credit	$	261,582		$	—
Term loan	208,418			222,694
Senior unsecured notes	6,564,842			6,712,624
Mortgage debt	1,653,426			1,676,544
Other debt	78,633			81,958
Intangible liabilities, net	108,864			105,909
Accounts payable and accrued liabilities	313,627			293,994
Deferred revenue	64,142			68,055
Total liabilities(2)	9,253,534			9,161,778

Commitments and contingencies

Common stock, $1.00 par value: 750,000,000 shares authorized; 455,094,411 and 453,191,321 shares issued and outstanding, respectively	455,094			453,191
Additional paid-in capital	11,254,658			11,180,066
Cumulative dividends in excess of earnings	(1,100,834		)	(1,067,367		)
Accumulated other comprehensive loss	(12,360		)	(14,653		)
Total stockholders’ equity	10,596,558			10,551,237

Joint venture partners	16,910			14,752
Non-managing member unitholders	184,791			187,788
Total noncontrolling interests	201,701			202,540
Total equity	10,798,259			10,753,777
Total liabilities and equity	$	20,051,793		$	19,915,555

(1) The Company’s consolidated total assets at December 31, 2012, include assets of certain variable interest entities (“VIEs”) that can only be used to settle the liabilities of those VIEs as follows: accounts receivable, net, $2 million; cash and cash equivalents, $10 million; and other assets, net, $2 million. See Note 16 to the Condensed Consolidated Financial Statements for additional information.

(2) The Company’s consolidated total liabilities at December 31, 2012, include liabilities of certain VIEs for which the VIE creditors do not have recourse to HCP, Inc. as follows: other debt, $0.2 million; accounts payable and accrued liabilities, $14 million; and deferred revenue, $2 million. See Note 16 to the Condensed Consolidated Financial Statements for additional information.

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

HCP, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(In thousands, except per share data)

(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Revenues:
Rental and related revenues	$	280,616		$	244,603		$	565,251		$	484,859
Tenant recoveries	25,146			23,581			49,349			46,231
Resident fees and services	37,590			35,569			74,481			71,748
Income from direct financing leases	158,286			154,976			315,156			309,511
Interest income	14,147			1,216			26,533			2,035
Investment management fee income	499			470			942			963
Total revenues	516,284			460,415			1,031,712			915,347

Costs and expenses:
Interest expense	108,716			102,354			218,006			206,044
Depreciation and amortization	110,686			84,873			215,314			170,062
Operating	74,814			70,076			148,419			137,409
General and administrative	24,073			14,801			44,744			34,884
Total costs and expenses	318,289			272,104			626,483			548,399

Other income, net	3,240			1,028			15,303			1,462

Income before income taxes and equity income from unconsolidated joint ventures	201,235			189,339			420,532			368,410
Income taxes	(1,654		)	(171		)	(2,530		)	541
Equity income from unconsolidated joint ventures	15,585			15,732			30,386			29,407
Income from continuing operations	215,166			204,900			448,388			398,358

Discontinued operations:
Income before gain on sales of real estate	672			75			1,234			325
Gain on sales of real estate	887			—			887			2,856
Total discontinued operations	1,559			75			2,121			3,181

Net income	216,725			204,975			450,509			401,539
Noncontrolling interests’ share in earnings	(3,324		)	(2,951		)	(6,523		)	(6,135		)
Net income attributable to HCP, Inc.	213,401			202,024			443,986			395,404
Preferred stock dividends	—			—			—			(17,006		)
Participating securities’ share in earnings	(378		)	(557		)	(856		)	(1,674		)
Net income applicable to common shares	$	213,023		$	201,467		$	443,130		$	376,724

Basic earnings per common share:
Continuing operations	$	0.47		$	0.48		$	0.97		$	0.90
Discontinued operations	—			—			0.01			0.01
Net income applicable to common shares	$	0.47		$	0.48		$	0.98		$	0.91
Diluted earnings per common share:
Continuing operations	$	0.47		$	0.48		$	0.97		$	0.90
Discontinued operations	—			—			—			—
Net income applicable to common shares	$	0.47		$	0.48		$	0.97		$	0.90
Weighted average shares used to calculate earnings per common share:
Basic	454,618			420,468			454,137			415,243
Diluted	455,431			421,671			455,024			416,666

Dividends declared per common share	$	0.525		$	0.50		$	1.05		1.00

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

HCP, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(In thousands)

(Unaudited)

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012

Net income	$	216,725		$	204,975		$	450,509		$	401,539

Other comprehensive income (loss):
Unrealized gains on securities:
Unrealized gains (losses)	—			(961		)	1,355			343
Reclassification adjustment realized in net income	—			—			(9,131		)	—
Change in net unrealized gains on cash flow hedges:
Unrealized gains (losses)	4,025			(1,056		)	9,345			(780		)
Reclassification adjustment realized in net income	288			90			560			179
Change in Supplemental Executive Retirement Plan obligation	55			45			111			90
Foreign currency translation adjustment	(125		)	(155		)	53			47
Total other comprehensive income (loss)	4,243			(2,037		)	2,293			(121		)

Total comprehensive income	220,968			202,938			452,802			401,418
Total comprehensive income attributable to noncontrolling interests	(3,324		)	(2,951		)	(6,523		)	(6,135		)
Total comprehensive income attributable to HCP, Inc.	$	217,644		$	199,987		$	446,279		$	395,283

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

HCP, INC.

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(In thousands, except per share data)

(Unaudited)

									Cumulative			Accumulated
						Additional			Dividends			Other			Total			Total
	Common Stock					Paid-In			In Excess			Comprehensive			Stockholders’			Noncontrolling			Total
	Shares		Amount			Capital			Of Earnings			Income (Loss)			Equity			Interests			Equity
January 1, 2013	453,191		$	453,191		$	11,180,066		$	(1,067,367	)	$	(14,653	)	$	10,551,237		$	202,540		$	10,753,777
Net income	—		—			—			443,986			—			443,986			6,523			450,509
Other comprehensive income	—		—			—			—			2,293			2,293			—			2,293
Issuance of common stock, net	1,097		1,097			49,221			—			—			50,318			(2,997		)	47,321
Repurchase of common stock	(46	)	(46		)	(2,224		)	—			—			(2,270		)	—			(2,270		)
Exercise of stock options	852		852			15,957			—			—			16,809			—			16,809
Amortization of deferred compensation	—		—			11,638			—			—			11,638			—			11,638
Common dividends ($1.05 per share)	—		—			—			(477,453		)	—			(477,453		)	—			(477,453		)
Distributions to noncontrolling interests	—		—			—			—			—			—			(7,506		)	(7,506		)
Issuance of noncontrolling interests	—		—			—			—			—			—			3,141			3,141
June 30, 2013	455,094		$	455,094		$	11,254,658		$	(1,100,834	)	$	(12,360	)	$	10,596,558		$	201,701		$	10,798,259

														Cumulative			Accumulated
											Additional			Dividends			Other			Total			Total
	Preferred Stock					Common Stock					Paid-In			In Excess			Comprehensive			Stockholders’			Noncontrolling			Total
	Shares		Amount			Shares		Amount			Capital			Of Earnings			Income (Loss)			Equity			Interests			Equity
January 1, 2012	11,820		$	285,173		408,629		$	408,629		$	9,383,536		$	(1,024,274	)	$	(19,582	)	$	9,033,482		$	187,140		$	9,220,622
Net income	—		—			—		—			—			395,404			—			395,404			6,135			401,539
Other comprehensive loss	—		—			—		—			—			—			(121		)	(121		)	—			(121		)
Preferred stock redemption	(11,820	)	(285,173		)	—		—			—			(10,327		)	—			(295,500		)	—			(295,500		)
Issuance of common stock, net	—		—			18,912		18,912			737,145			—			—			756,057			(2,273		)	753,784
Repurchase of common stock	—		—			(189	)	(189		)	(7,678		)	—			—			(7,867		)	—			(7,867		)
Exercise of stock options	—		—			2,050		2,050			35,170			—			—			37,220			—			37,220
Amortization of deferred compensation	—		—			—		—			11,407			—			—			11,407			—			11,407
Preferred dividends	—		—			—		—			—			(6,679		)	—			(6,679		)	—			(6,679		)
Common dividends ($1.00 per share)	—		—			—		—			—			(416,173		)	—			(416,173		)	—			(416,173		)
Distributions to noncontrolling interests	—		—			—		—			—			—			—			—			(7,778		)	(7,778		)
Issuance of noncontrolling interests	—		—			—		—			—			—			—			—			873			873
Purchase of noncontrolling interests	—		—			—		—			—			—			—			—			(388		)	(388		)
June 30, 2012	—		$	—		429,402		$	429,402		$	10,159,580		$	(1,062,049	)	$	(19,703	)	$	9,507,230		$	183,709		$	9,690,939

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

HCP, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)
(Unaudited)

	Six Months Ended June 30,
	2013			2012
Cash flows from operating activities:
Net income	$	450,509		$	401,539
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	215,314			170,062
Discontinued operations	170			6,138
Amortization of above and below market lease intangibles, net	(6,068		)	(1,322		)
Amortization of deferred compensation	11,638			11,407
Amortization of deferred financing costs, net	9,440			8,459
Straight-line rents	(15,955		)	(21,787		)
Loan and direct financing lease interest accretion	(45,539		)	(48,159		)
Deferred rental revenues	(965		)	1,169
Equity income from unconsolidated joint ventures	(30,386		)	(29,407		)
Distributions of earnings from unconsolidated joint ventures	1,624			1,878
Gain on sales of real estate	(887		)	(2,856		)
Marketable securities gain on sales, net	(10,977		)	—
Foreign currency and derivative (gains) losses, net	780			(52		)
Changes in:
Accounts receivable, net	462			708
Other assets	(12,852		)	(8,188		)
Accounts payable and accrued liabilities	5,294			(6,038		)
Net cash provided by operating activities	571,602			483,551
Cash flows from investing activities:
Acquisitions of real estate	(60,353		)	(10,970		)
Development of real estate	(67,983		)	(51,890		)
Leasing costs and tenant and capital improvements	(19,938		)	(27,112		)
Proceeds from sales of real estate, net	3,777			7,238
Distributions in excess of earnings from unconsolidated joint ventures	904			1,529
Purchases of marketable debt securities	(16,706		)	(214,859		)
Proceeds from the sale of marketable securities	28,030			—
Principal repayments on loans receivable	19,112			4,508
Investments in loans receivable	(300,673		)	(20,757		)
Increase in restricted cash	(7,105		)	(1,229		)
Net cash used in investing activities	(420,935		)	(313,542		)
Cash flows from financing activities:
Net borrowings (repayments) under bank line of credit	265,049			(238,985		)
Issuance of senior unsecured notes	—			450,000
Repayments of senior unsecured notes	(150,000		)	(250,000		)
Repayments of mortgage debt	(40,380		)	(42,538		)
Deferred financing costs	—			(10,236		)
Preferred stock redemption	—			(295,500		)
Net proceeds from the issuance of common stock and exercise of options	61,860			783,137
Dividends paid on common and preferred stock	(477,453		)	(422,852		)
Issuance of noncontrolling interests	3,141			873
Distributions to noncontrolling interests	(7,506		)	(7,778		)
Net cash used in financing activities	(345,289		)	(33,879		)
Effect of foreign exchange on cash and cash equivalents	63			—
Net increase (decrease) in cash and cash equivalents	(194,559		)	136,130
Cash and cash equivalents, beginning of period	247,673			33,506
Cash and cash equivalents, end of period	$	53,114		$	169,636

See accompanying Notes to the Condensed Consolidated Financial Statements.

Table of Contents

HCP, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) Business

HCP, Inc., an S&P 500 company, together with its consolidated entities (collectively, “HCP” or the “Company”), invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). The Company is a Maryland corporation and was organized to qualify as a self-administered real estate investment trust (“REIT”) in 1985. The Company is headquartered in Long Beach, California, with offices in Nashville, Tennessee and San Francisco, California. The Company acquires, develops, leases, manages and disposes of healthcare real estate, and provides financing to healthcare providers. The Company’s portfolio is comprised of investments in the following five healthcare segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. The Company makes investments within the healthcare segments using the following five investment products: (i) properties under lease, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management and (v) investments in senior housing operations utilizing the structure permitted by the Housing and Economic Recovery Act of 2008, which is commonly referred to as “RIDEA.”

(2) Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information. Management is required to make estimates and assumptions in the preparation of financial statements in conformity with GAAP. These estimates and assumptions affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from management’s estimates.

The condensed consolidated financial statements include the accounts of HCP, Inc., its wholly-owned subsidiaries and joint ventures or variable interest entities (“VIEs”) that it controls through voting rights or other means. Intercompany transactions and balances have been eliminated upon consolidation. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) necessary to present fairly the Company’s financial position, results of operations and cash flows have been included. Operating results for the six months ended June 30, 2013 are not necessarily indicative of the results that may be expected for the year ending December 31, 2013. The accompanying unaudited interim financial information should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2012 included in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (the “SEC”).

Certain amounts in the Company’s condensed consolidated financial statements have been reclassified for prior periods to conform to the current period presentation. Assets sold or held for sale and associated liabilities have been reclassified on the condensed consolidated balance sheets and the related operating results reclassified from continuing to discontinued operations on the condensed consolidated statements of income (see Note 4).

Acquisition Costs

Transaction costs related to acquisitions of businesses, including properties, are expensed as incurred.

Recent Accounting Pronouncements

In February 2013, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2013-02, Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income (“ASU 2013-02”). This update requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. In addition, an entity is required to present, either on the face of the statement where net income is presented or in the notes, significant amounts reclassified out of accumulated other comprehensive income by the respective line items of net income. The adoption of ASU 2013-02 on January 1, 2013 did not have a material impact on the Company’s consolidated financial position or results of operations.

In July 2012, the FASB issued Accounting Standards Update No. 2012-01, Continuing Care Retirement Communities—Refundable Advance Fees (“ASU 2012-01”). This update clarifies the situations in which recognition of deferred revenue for refundable advance fees is appropriate. The adoption of ASU 2012-01 on January 1, 2013 did not have a material impact on the Company’s consolidated financial position or results of operations.

Table of Contents

(3) Real Estate Property Investments

$1.73 Billion Senior Housing Portfolio Acquisition (the “Blackstone JV Acquisition”)

During the fourth quarter of 2012 and first quarter of 2013, the Company acquired 133 senior housing communities for $1.73 billion from a joint venture between Emeritus Corporation (“Emeritus”) and Blackstone Real Estate Partners VI, an affiliate of the Blackstone Group (the “Blackstone JV”). Located in 29 states, the portfolio encompasses a diversified care mix of 61% assisted living, 25% independent living, 13% memory care and 1% skilled nursing based on units. Based on operating performance at closing, the 133 communities consisted of 99 that were stabilized and 34 that were in lease-up. The transaction closed in two stages: (i) 129 senior housing facilities during the fourth quarter of 2012 for $1.7 billion; and (ii) four senior housing facilities during the first quarter of 2013 for $38 million. The Company paid $1.73 billion in cash consideration and assumed $13 million of mortgage debt to acquire: (i) real estate with a fair value of $1.57 billion, (ii) intangible assets with a fair value of $174 million; and (iii) assumed intangible liabilities with a fair value of $4 million. As of June 30, 2013, the purchase price allocation is preliminary, and the final purchase price allocation will be determined pending the receipt of information necessary to complete the valuation of certain assets and liabilities, which may result in changes from the initial estimates.

Emeritus operates the communities pursuant to a new triple-net master lease for 128 properties (the “Master Lease”) and five individual leases, all guaranteed by Emeritus (together, the “Leases”). The Leases provide aggregate contractual rent in the first year of $105.8 million. The contractual rent will increase annually by the greater of the percentage increase in the Consumer Price Index (“CPI”) or 3.7% on average over the initial five years, and thereafter by the greater of CPI or 3.0% for the remaining initial lease term. At the beginning of the sixth lease year, rent on the 34 lease-up properties will increase to the greater of the percentage increase in CPI or fair market, subject to a floor of 103% and a cap of 130% of the prior year’s rent.

The Master Lease properties are grouped into three pools that share comparable characteristics. The Leases have initial terms of 14 to 16 years. Emeritus has two extension options, which, if exercised, will provide for lease terms of 30 to 35 years.

Concurrent with the acquisition in 2012, Emeritus purchased nine communities from the Blackstone JV, for which the Company provided secured debt financing of $52 million with a four-year term. The loan is secured by the underlying real estate and is prepayable at Emeritus’ option. The interest rate on the loan was initially 6.1% and will gradually increase during its four year term to 6.8%.

Pro Forma Results of Operations

The following unaudited pro forma consolidated results of operations assume that the Blackstone JV Acquisition was completed as of January 1, 2012 (in thousands, except per share amounts):

	Three Months Ended June 30, 2012		Six Months Ended June 30, 2012
Revenues	$	486,865	$	968,247
Net income	212,380		416,349
Net income applicable to HCP, Inc.	209,429		410,214
Basic earnings per common share	0.47		0.90
Diluted earnings per common share	0.47		0.90

Other Real Estate Acquisitions

In addition to the Blackstone JV Acquisition (discussed above), during the six months ended June 30, 2013, the Company acquired a senior housing facility for $18 million, exercised its purchase option for a senior housing facility it previously leased for $16 million and acquired 38 acres of land in the post-acute/skilled nursing segment for $408,000.

During the six months ended June 30, 2012, the Company acquired a life science facility for $8 million and 13 acres of land in the hospital segment for $3 million.

Table of Contents

During the six months ended June 30, 2013 and 2012, the Company funded an aggregate of $76 million and $79 million, respectively, for construction, tenant and other capital improvement projects, primarily in its senior housing, life science and medical office segments.

(4) Dispositions of Real Estate and Discontinued Operations

During the six months ended June 30, 2013, the Company sold a senior housing facility for $4 million. During the six months ended June 30, 2012, the Company sold a medical office building for $7 million.

At June 30, 2013, one hospital was classified as held for sale, with a carrying value of $7 million. At December 31, 2012, properties classified as held for sale included a senior housing facility and hospital with a combined aggregate carrying value of $10 million.

The following table summarizes operating loss from discontinued operations and gain on sales of real estate included in discontinued operations (dollars in thousands):

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Rental and related revenues	$	779	$	4,024	$	1,620	$	8,349

Depreciation and amortization expenses	81		3,051		170		6,138
Operating expenses	—		11		—		29
Other expense, net	26		887		216		1,857
Income before gain on sales of real estate	$	672	$	75	$	1,234	$	325
Gain on sales of real estate, net of income taxes	$	887	$	—	$	887	$	2,856

Number of properties included in discontinued operations	2		5		2		6

(5) Net Investment in Direct Financing Leases

The components of net investment in direct financing leases (“DFLs”) consisted of the following (dollars in thousands):

	June 30,			December 31,
	2013			2012
Minimum lease payments receivable(1)	$	24,948,287		$	25,217,520
Estimated residual values	4,010,514			4,010,514
Less unearned income	(22,000,672		)	(22,346,641		)
Net investment in direct financing leases	$	6,958,129		$	6,881,393
Properties subject to direct financing leases	361			361

(1) The minimum lease payments receivable are primarily attributable to HCR ManorCare, Inc. (“HCR ManorCare”) ($23.8 billion and $24.0 billion at June 30, 2013 and December 31, 2012, respectively). The triple-net master lease with HCR ManorCare provides for annual rent of $506 million beginning April 1, 2013 (prior to April 1, 2013, annual rent was $489 million). The rent increases by 3.5% per year over the next three years and by 3% for the remaining portion of the initial lease term. The properties are grouped into four pools, and HCR ManorCare has a one-time extension option for each pool with rent increased for the first year of the extension option to the greater of fair market rent or a 3% increase over the rent for the prior year. Including the extension options, which the Company determined to be bargain renewal options, the four leased pools had total initial available terms ranging from 23 to 35 years.

Certain leases contain provisions that allow the tenants to elect to purchase the properties during or at the end of the lease terms for the aggregate initial investment amount plus adjustments, if any, as defined in the lease agreements. Certain leases also permit the Company to require the tenants to purchase the properties at the end of the lease terms.

Table of Contents

(6) Loans Receivable

The following table summarizes the Company’s loans receivable (in thousands):

	June 30, 2013								December 31, 2012
	Real Estate Secured		Other Secured			Total			Real Estate Secured		Other Secured			Total
Mezzanine	$	—	$	428,723		$	428,723		$	—	$	145,150		$	145,150
Other	161,957		—			161,957			147,264		—			147,264
Unamortized discounts, fees and costs	—		(21,479		)	(21,479		)	—		(2,974		)	(2,974		)
Allowance for loan losses	—		(13,410		)	(13,410		)	—		(13,410		)	(13,410		)
	$	161,957	$	393,834		$	555,791		$	147,264	$	128,766		$	276,030

Barchester Loan

On May 2, 2013, the Company acquired £121 million of subordinated debt at a discount for £109 million. The loan is secured by an interest in 160 facilities leased and operated by Barchester Healthcare (“Barchester”). This loan matures in September 2013 and bears interest on its face value at a floating rate of London Interbank Offered Rate (“LIBOR”) plus a weighted-average margin of 3.14%. At June 30, 2013, the carrying value of this loan was $165 million. This loan investment was financed by a GBP denominated draw on the Company’s revolving line of credit facility that is discussed in Note 10.

Tandem Health Care Loan

On July 31, 2012, the Company closed a mezzanine loan facility to lend up to $205 million to Tandem Health Care (“Tandem”), an affiliate of Formation Capital, as part of the recapitalization of a post-acute/skilled nursing portfolio. At closing, the loan was subordinate to $400 million in senior mortgage debt and $137 million in senior mezzanine debt. The Company funded $100 million (the “First Tranche”) at closing and funded an additional $102 million (the “Second Tranche”) in June 2013. The Second Tranche was used to repay the senior mezzanine debt. At June 30, 2013, the loan was subordinate to $444 million of senior mortgage debt. The loan bears interest at a fixed rate of 12% and 14% per annum for the First and Second Tranches, respectively. The facility has a total term of up to 63 months from the initial closing, is prepayable at the borrower’s option and is secured by real estate partnership interests. The loan is subject to a prepayment premium if repaid on or before the third anniversary from the initial closing date.

Delphis Operations, L.P. Loan

The Company holds a secured term loan made to Delphis Operations, L.P. (“Delphis” or the “Borrower”) that is collateralized by all of the assets of the Borrower. The Borrower’s collateral is comprised primarily of interests in partnerships operating surgical facilities, some of which are on the premises of properties owned by the Company or HCP Ventures IV, LLC, an unconsolidated joint venture of the Company. In December 2009, the Company determined that the loan was impaired. Further, in January 2011 the Company placed the loan on cost-recovery status, whereby accrual of interest income was suspended and any payments received from the Borrower are applied to reduce the recorded investment in the loan.

As part of a March 2012 agreement (the “2012 Agreement”) between Delphis, certain past and current principals of Delphis and the Cirrus Group, LLC (the “Guarantors”), and the Company, the Company agreed, among other things, to allow the distribution of $1.5 million to certain of the Guarantors from funds generated from sales of assets that were pledged as additional collateral for this loan. Further, the Company, as part of the 2012 Agreement, agreed to provide financial incentives to the Borrower regarding the liquidation of the primary collateral assets for this loan.

Pursuant to the 2012 Agreement, the Company received the remaining cash ($4.8 million, after reducing this amount by $0.5 million for related legal expenses) and other consideration ($2.1 million) of $6.9 million from the Guarantors. In addition, during 2012 the Company received $38.1 million in net proceeds from the sales of two of the primary collateral assets, which proceeds, together with the cash payments and other consideration, were applied to reduce the carrying value of the loan. The carrying value of the loan was $29.2 million and $30.7 million at June 30, 2013 and December 31, 2012, respectively. During the three and six months ended June 30, 2013, the Company received cash payments from the Borrower of $1.5 million. At June 30, 2013, the Company believes the fair value of the collateral supporting this loan is in excess of its carrying value.

Table of Contents

(7) Investments in and Advances to Unconsolidated Joint Ventures

The Company owns interests in the following entities that are accounted for under the equity method at June 30, 2013 (dollars in thousands):

Entity(1)	Properties/Segment	Investment(2)			Ownership%
HCR ManorCare	post-acute/skilled nursing operations	$	88,018		9.5(3)
HCP Ventures III, LLC	13 medical office	7,335			30
HCP Ventures IV, LLC	54 medical office and 4 hospital	31,049			20
HCP Life Science(4)	4 life science	68,779			50-63
Horizon Bay Hyde Park, LLC	1 senior housing	6,496			72
Suburban Properties, LLC	1 medical office	6,950			67
Advances to unconsolidated joint ventures, net		251
		$	208,878

Edgewood Assisted Living Center, LLC	1 senior housing	$	(387	)	45
Seminole Shores Living Center, LLC	1 senior housing	(634		)	50
		$	(1,021	)

(1) These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.

(2) Represents the carrying value of the Company’s investment in the unconsolidated joint venture.

(3) Presented after adjusting the Company’s 9.9% ownership for the dilution of certain of HCR ManorCare’s outstanding employee equity awards.

(4) Includes three unconsolidated joint ventures between the Company and an institutional capital partner for which the Company is the managing member. HCP Life Science includes the following partnerships: (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).

Summarized combined financial information for the Company’s unconsolidated joint ventures follows (in thousands):

	June 30,		December 31,
	2013		2012
Real estate, net	$	3,690,920	$	3,731,740
Goodwill and other assets, net	5,807,180		5,734,318
Total assets	$	9,498,100	$	9,466,058

Capital lease obligations and mortgage debt	$	6,813,884	$	6,875,932
Accounts payable	1,047,460		971,095
Other partners’ capital	1,452,467		1,435,885
HCP’s capital(1)	184,289		183,146
Total liabilities and partners’ capital	$	9,498,100	$	9,466,058

(1) The combined basis difference of the Company’s investments in these joint ventures of $23 million, as of June 30, 2013, is primarily attributable to goodwill, real estate, capital lease obligations, deferred tax assets and lease related net intangibles.

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
Total revenues	$	1,059,412	$	1,093,873	$	2,152,863	$	2,138,519
Net income	10,122		16,124		20,494		17,267
HCP’s share in earnings (1)	15,585		15,732		30,386		29,407
Fees earned by HCP	499		470		942		963
Distributions received by HCP	1,157		1,278		2,528		3,407

(1) The Company’s joint venture interest in HCR ManorCare is accounted for using the equity method and results in an ongoing reduction of DFL income, proportional to HCP’s ownership in HCR ManorCare. The Company recorded a reduction of $15 million for both the three months ended June 30, 2013 and 2012. The Company recorded a reduction of $31 million and $30 million for the six months ended June 30, 2013 and 2012, respectively. Further, the Company’s share of earnings from HCR ManorCare (equity income) increases for the corresponding reduction of related lease expense recognized at the HCR ManorCare level.

Table of Contents

(8) Intangibles

At both June 30, 2013 and December 31, 2012, intangible lease assets, comprised of lease-up intangibles, above market tenant lease intangibles and below market ground lease intangibles, were $794 million. At June 30, 2013 and December 31, 2012, the accumulated amortization of intangible assets was $275 million and $241 million, respectively.

At June 30, 2013 and December 31, 2012, intangible lease liabilities, comprised of below market lease intangibles and above market ground lease intangible liabilities were $215 and $199 million, respectively. At June 30, 2013 and December 31, 2012, the accumulated amortization of intangible liabilities was $106 million and $93 million, respectively.

(9) Other Assets

The Company’s other assets consisted of the following (in thousands):

	June 30,		December 31,
	2013		2012
Straight-line rent assets, net of allowance of $34,147 and $33,521, respectively	$	339,464	$	306,294
Marketable debt securities(1)	225,285		222,809
Leasing costs, net	98,408		93,763
Deferred financing costs, net	39,986		45,490
Goodwill	50,346		50,346
Marketable equity securities	—		24,829
Other(2)	56,827		44,989
Total other assets	$	810,316	$	788,520

(1) Includes £136.9 million ($208 million and $223 million at June 30, 2013 and December 31, 2012, respectively) of Four Seasons senior unsecured notes translated into U.S. dollars (see below for additional information).

(2) Includes a $5.4 million allowance for losses related to accrued interest receivable on the Delphis loan, which accrued interest is included in other assets. At both June 30, 2013 and December 31, 2012, the carrying value of interest accrued related to the Delphis loan was zero. See Note 6 for additional information about the Delphis loan and the related impairment. At both June 30, 2013 and December 31, 2012, includes a loan receivable of $10 million from HCP Ventures IV, LLC, an unconsolidated joint venture (see Note 7 for additional information) with an interest rate of 12% which matures in May 2014. The loan is secured by HCP’s joint venture partner’s 80% partnership interest in the joint venture.

During the six months ended June 30, 2013, the Company realized gains from the sale of marketable equity securities of $11 million, which were included in other income, net. At December 31, 2012, the fair value and adjusted cost basis of the marketable equity securities were $24.8 million and $17.1 million, respectively. The marketable equity securities were classified as available-for-sale.

Four Seasons Health Care Senior Unsecured Notes

On June 28, 2012, the Company purchased senior unsecured notes with an aggregate par value of £138.5 million at a discount for £136.8 million ($214.9 million). The notes were issued by Elli Investments Limited, a subsidiary of Terra Firma, a European private equity firm, as part of its financing for the acquisition of Four Seasons Health Care (“Four Seasons”), an elderly and specialist care provider in the United Kingdom. The notes mature in June 2020 and are non-callable through June 2016. The notes bear interest on their par value at a fixed rate of 12.25% per annum, with an original issue discount resulting in a yield to maturity of 12.5%. This investment was financed by a GBP denominated unsecured term loan that is discussed in Note 10. These senior unsecured notes are accounted for as marketable debt securities and classified as held-to-maturity.

(10) Debt

Bank Line of Credit and Term Loan

The Company’s $1.5 billion unsecured revolving line of credit facility (the “Facility”) matures in March 2016 and contains a one-year extension option. Borrowings under the Facility accrue interest at LIBOR plus a margin that depends on the Company’s debt ratings. The Company pays a facility fee on the entire revolving commitment that depends upon its debt ratings. Based on the Company’s debt ratings at June 30, 2013, the margin on the Facility was 1.075%, and the facility fee was 0.175%. The Facility also includes a feature that will allow the Company to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At June 30, 2013, the Company had $262 million (includes £109 million translated into U.S. dollars) outstanding under the Facility.

Table of Contents

On July 30, 2012, the Company entered into a credit agreement with a syndicate of banks for a £137 million ($208 million at June 30, 2013) four-year unsecured term loan (the “Term Loan”) that accrues interest at a rate of GBP LIBOR plus 1.20%, based on the Company’s current debt ratings. Concurrent with the closing of the Term Loan, the Company entered into a four-year interest rate swap contract that fixes the interest rate of the Term Loan at 1.81%, subject to adjustments based on the Company’s debt ratings. The Term Loan contains a one-year committed extension option.

The Facility and Term Loan contain certain financial restrictions and other customary requirements, including cross-default provisions to other indebtedness. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60%, (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times and (v) require a formula-determined Minimum Consolidated Tangible Net Worth of $9.2 billion at June 30, 2013. At June 30, 2013, the Company was in compliance with each of these restrictions and requirements of the Facility and Term Loan.

Senior Unsecured Notes

At June 30, 2013, the Company had senior unsecured notes outstanding with an aggregate principal balance of $6.6 billion. At June 30, 2013, interest rates on the notes ranged from 1.24% to 6.98% with a weighted average effective interest rate of 5.10% and a weighted average maturity of six years. Discounts and premiums are amortized to interest expense over the term of the related senior unsecured notes. The senior unsecured notes contain certain covenants including limitations on debt, cross-acceleration provisions and other customary terms. The Company believes it was in compliance with these covenants at June 30, 2013.

On February 28, 2013, the Company repaid $150 million of maturing 5.625% senior unsecured notes.

On November 19, 2012, the Company issued $800 million of 2.625% senior unsecured notes due in 2020. The notes were priced at 99.7% of the principal amount with an effective yield to maturity of 2.7%; net proceeds from this offering were $793 million.

On July 23, 2012, the Company issued $300 million of 3.15% senior unsecured notes due in 2022. The notes were priced at 98.9% of the principal amount with an effective yield to maturity of 3.3%; net proceeds from the offering were $294 million.

On June 25, 2012, the Company repaid $250 million of maturing 6.45% senior unsecured notes. The senior unsecured notes were repaid with proceeds from the Company’s June 2012 common stock offering.

On January 23, 2012, the Company issued $450 million of 3.75% senior unsecured notes due in 2019. The notes were priced at 99.5% of the principal amount with an effective yield to maturity of 3.8%; net proceeds from the offering were $444 million.

Mortgage Debt

At June 30, 2013, the Company had $1.7 billion in aggregate principal amount of mortgage debt outstanding that is secured by 138 healthcare facilities (including redevelopment properties) with a carrying value of $2.1 billion. At June 30, 2013, interest rates on the mortgage debt ranged from 0.69% to 8.69% with a weighted average effective interest rate of 6.12% and a weighted average maturity of three years.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by real estate assets and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered assets, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets and includes conditions to obtain lender consent to enter into or terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple assets and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

Table of Contents

Other Debt

At June 30, 2013, the Company had $79 million of non-interest bearing life care bonds at two of its continuing care retirement communities and non-interest bearing occupancy fee deposits at two of its senior housing facilities, all of which were payable to certain residents of the facilities (collectively, “Life Care Bonds”). The Life Care Bonds are refundable to the residents upon the termination of the contract or upon the successful resale of the unit.

Debt Maturities

The following table summarizes the Company’s stated debt maturities and scheduled principal repayments at June 30, 2013 (in thousands):

Year	Line of Credit(1)		Term Loan(2)		Senior Unsecured Notes			Mortgage Debt			Total(3)
2013 (Six months)	$	—	$	—	$	400,000		$	254,973		$	654,973
2014	—		—		487,000			180,221			667,221
2015	—		—		400,000			308,611			708,611
2016	261,582		208,418		900,000			291,941			1,661,941
2017	—		—		750,000			550,788			1,300,788
Thereafter	—		—		3,650,000			73,468			3,723,468
	261,582		208,418		6,587,000			1,660,002			8,717,002
(Discounts) and premiums, net	—		—		(22,158		)	(6,576		)	(28,734		)
	$	261,582	$	208,418	$	6,564,842		$	1,653,426		$	8,688,268

(1) Includes £109 million translated into U.S. dollars.

(2) Represents £137 million translated into U.S. dollars.

(3) Excludes $79 million of other debt that represents the Life Care Bonds that have no scheduled maturities.

(11) Commitments and Contingencies

Legal Proceedings

From time to time, the Company is a party to legal proceedings, lawsuits and other claims that arise in the ordinary course of the Company’s business. The Company is not aware of any legal proceedings or claims that it believes may have, individually or taken together, a material adverse effect on the Company’s business, prospects, financial condition, results of operations or cash flows. The Company’s policy is to expense legal costs as they are incurred.

Concentration of Credit Risk

Concentrations of credit risks arise when a number of operators, tenants or obligors related to the Company’s investments are engaged in similar business activities, or activities in the same geographic region, or have similar economic features that would cause their ability to meet contractual obligations, including those to the Company, to be similarly affected by changes in economic conditions. The Company regularly monitors various segments of its portfolio to assess potential concentrations of risks. The Company does not have significant foreign operations.

Table of Contents

The following table provides information regarding the Company’s concentrations with respect to certain operators and tenants; the information provided is presented for the gross assets and revenues that are associated with certain operators and tenants as percentages of the respective segment’s and total Company’s gross assets and revenues:

Segment Concentrations:

	Percentage of Senior Housing Gross Assets				Percentage of Senior Housing Revenues				Percentage of Senior Housing Revenues
	June 30,		December 31,		Three Months Ended June 30,				Six Months Ended June 30,
Operators	2013		2012		2013		2012		2013		2012
Emeritus	35	%	35	%	35	%	23	%	35	%	21	%
Sunrise Senior Living (“Sunrise”)(1)	17		17		13		17		13		16
HCR ManorCare	11		11		9		13		9		12
Brookdale Senior Living (“Brookdale”)(2)	10		11		11		16		12		14

	Percentage of Post-Acute/ Skilled Nursing Gross Assets				Percentage of Post-Acute/ Skilled Nursing Revenues				Percentage of Post-Acute/ Skilled Nursing Revenues
	June 30,		December 31,		Three Months Ended June 30,				Six Months Ended June 30,
Operators	2013		2012		2013		2012		2013		2012
HCR ManorCare	86	%	89	%	86	%	93	%	86	%	93	%

Total Company Concentrations:

	Percentage of Total Company Gross Assets				Percentage of Total Company Revenues				Percentage of Total Company Revenues
	June 30,		December 31,		Three Months Ended June 30,				Six Months Ended June 30,
Operators	2013		2012		2013		2012		2013		2012
HCR ManorCare	32	%	31	%	28	%	31	%	28	%	31	%
Emeritus	14		13		13		7		13		7
Sunrise(1)	7		7		5		5		5		5
Brookdale(2)	4		4		4		5		4		5

(1) Certain of the Company’s properties are leased to tenants who have entered into management contracts with Sunrise to operate the respective property on their behalf. The Company’s concentration of gross assets includes properties directly leased to Sunrise and properties that are managed by Sunrise on behalf of third party tenants.

(2) At June 30, 2013 and December 31, 2012, Brookdale percentages exclude $705 million and $692 million, respectively, of senior housing assets related to 21 senior housing facilities that Brookdale operates on the Company’s behalf under a RIDEA structure. Assuming that these assets were attributable to Brookdale, the percentage of segment assets for Brookdale would be 19% and 20% at June 30, 2013 and December 31, 2012, respectively. Assuming that these assets were attributable to Brookdale, the percentage of total assets for Brookdale would be 8% at both June 30, 2013 and December 31, 2012. For the three and six months ended June 30, 2013, Brookdale percentages exclude $37.6 million and $74.4 million, respectively, of senior housing revenues related to these facilities. Assuming that these revenues were attributable to Brookdale, the percentage of segment revenues for Brookdale would be 31% for both the three and six months ended June 30, 2013. Assuming that these revenues were attributable to Brookdale, the percentage of total revenues for Brookdale would be 12% and 11%, respectively, for the three and six months ended June 30, 2013. For the three and six months ended June 30, 2012, Brookdale percentages exclude $35.6 million and $70.7 million, respectively, of senior housing revenues related to these facilities. Assuming that these revenues were attributable to Brookdale, the percentage of segment revenues for Brookdale would be 42% and 38% for the three and six months ended June 30, 2012, respectively. Assuming that these revenues were attributable to Brookdale, the percentage of total revenues for Brookdale would be 12% for both the three and six months ended June 30, 2012.

HCR ManorCare’s summarized condensed consolidated financial information follows (in millions):

	June 30,		December 31,
	2013		2012
Real estate and other property, net	$	3,019.9	$	3,046.6
Cash and cash equivalents	161.5		120.5
Goodwill, intangible and other assets, net	5,566.9		5,625.4
Total assets	$	8,748.3	$	8,792.5

Debt and financing obligations	$	6,319.0	$	6,374.6
Accounts payable, accrued liabilities and other	1,011.8		1,021.9
Total equity	1,417.5		1,396.0
Total liabilities and equity	$	8,748.3	$	8,792.5

Table of Contents

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012

Revenues	$	1,032.7		$	1,034.3		$	2,101.4		$	2,075.5
Operating, general and administrative expense	(876.9		)	(897.5		)	(1,789.3		)	(1,782.9		)
Depreciation and amortization expense	(36.4		)	(41.6		)	(73.7		)	(83.6		)
Interest expense	(104.1		)	(105.8		)	(208.5		)	(212.1		)
Other income (expense), net	(0.5		)	3.1			1.7			6.4

Income (loss) before income taxes	14.8			(7.5		)	31.6			3.3
Income taxes	(4.7		)	4.6			(9.8		)	0.1
Net income (loss)	$	10.1		$	(2.9	)	$	21.8		$	3.4

To mitigate the credit risk of leasing properties to certain senior housing and post-acute/skilled nursing operators, leases with operators are often combined into portfolios that contain cross-default terms, so that if a tenant of any of the properties in a portfolio defaults on its obligations under its lease, the Company may pursue its remedies under the lease with respect to any of the properties in the portfolio. Certain portfolios also contain terms whereby the net operating profits of the properties are combined for the purpose of securing the funding of rental payments due under each lease.

Credit Enhancement Guarantee

Certain of the Company’s senior housing facilities serve as collateral for $114 million of debt (maturing May 1, 2025) that is owed by a previous owner of the facilities. This indebtedness is guaranteed by the previous owner who has an investment grade credit rating. These senior housing facilities, which are classified as DFLs, had a carrying value of $377 million as of June 30, 2013.

(12) Equity

Preferred Stock

On April 23, 2012, the Company redeemed all of its outstanding preferred stock consisting of 4,000,000 shares of its 7.25% Series E preferred stock and 7,820,000 shares of its 7.10% Series F preferred stock. The shares of Series E and Series F preferred stock were redeemed at a price of $25 per share, or $295.5 million in aggregate, plus all accrued and unpaid dividends to the redemption date. As a result of the redemption, which was announced on March 22, 2012, the Company incurred a charge of $10.4 million during the three months ended March 31, 2012 related to the original issuance costs of the preferred stock (this charge is presented as an additional preferred stock dividend in the Company’s condensed consolidated statements of income).

Common Stock

The following table lists the common stock cash dividends declared by the Company in 2013:

Declaration Date	Record Date	Amount Per Share		Dividend Payable Date
January 24	February 4	$	0.525	February 19
April 25	May 6	0.525		May 21
July 25	August 5	0.525		August 20

In October 2012, the Company completed a $979 million offering of 22 million shares of common stock at a price of $44.50, which proceeds were primarily used to fund the Blackstone JV Acquisition.

In June 2012, the Company completed a $376 million offering of 8.97 million shares of common stock at a price of $41.88 per share, which proceeds were primarily used to repay $250 million of maturing senior unsecured notes.

In March 2012, the Company completed a $359 million offering of 9.0 million shares of common stock at a price of $39.93 per share, which proceeds were primarily used to redeem all outstanding shares of the Company’s preferred stock.

Table of Contents

The following is a summary of the Company’s other common stock issuances (shares in thousands):

	Six Months Ended June 30,
	2013	2012
Dividend Reinvestment and Stock Purchase Plan	925	501
Conversion of DownREIT units(1)	85	67
Exercise of stock options	852	2,050
Vesting of restricted stock units(2)	103	378

(1) Non-managing member LLC units.

(2) Issued under the Company’s 2006 Performance Incentive Plan.

Accumulated Other Comprehensive Loss

The following is a summary of the Company’s accumulated other comprehensive loss (in thousands):

	June 30,			December 31,
	2013			2012
Unrealized gains on available for sale securities	$	—		$	7,776
Unrealized losses on cash flow hedges, net	(8,547		)	(18,452		)
Supplemental Executive Retirement Plan minimum liability	(3,039		)	(3,150		)
Cumulative foreign currency translation adjustment	(774		)	(827		)
Total accumulated other comprehensive loss	$	(12,360	)	$	(14,653	)

Noncontrolling Interests

At June 30, 2013, there were four million DownREIT units outstanding in four LLCs, for which the Company is the managing member. At June 30, 2013, the carrying and fair values of these DownREIT units were $185 million and $273 million, respectively.

(13) Segment Disclosures

The Company evaluates its business and makes resource allocations based on its five business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the senior housing, post-acute/skilled nursing, life science and hospital segments, the Company invests or co-invests primarily in single operator or tenant properties, through the acquisition and development of real estate and by debt issued by operators in these sectors. Under the medical office segment, the Company invests or co-invests through the acquisition and development of medical office buildings (“MOBs”) that are leased under gross, modified gross or triple-net leases, generally to multiple tenants, and which generally require a greater level of property management. The accounting policies of the segments are the same as those described in Note 2 to the Consolidated Financial Statements for the year ended December 31, 2012 in the Company’s Annual Report on Form 10-K filed with the SEC. There were no intersegment sales or transfers during the six months ended June 30, 2013 and 2012. The Company evaluates performance based upon property net operating income from continuing operations (“NOI”), adjusted NOI and interest income of the combined investments in each segment.

Non-segment assets consist primarily of corporate assets including cash, restricted cash, accounts receivable, net, marketable equity securities, deferred financing costs and, if any, real estate held-for-sale. Interest expense, depreciation and amortization and non-property specific revenues and expenses are not allocated to individual segments in determining the Company’s performance measure. See Note 11 for other information regarding concentrations of credit risk.

Table of Contents

Summary information for the reportable segments follows (in thousands):

For the three months ended June 30, 2013:

Segments	Rental Revenues(1)		Resident Fees and Services		Interest Income		Investment Management Fee Income		Total Revenues		NOI(2)		Adjusted NOI(2) (Cash NOI)
Senior housing	$	150,261	$	37,590	$	2,806	$	—	$	190,657	$	163,714	$	148,400
Post-acute/skilled	137,520		—		11,029		—		148,549		136,867		120,128
Life science	75,227		—		—		1		75,228		61,388		58,265
Medical office	90,174		—		—		498		90,672		54,956		53,857
Hospital	10,866		—		312		—		11,178		9,899		21,609
Total	$	464,048	$	37,590	$	14,147	$	499	$	516,284	$	426,824	$	402,259

For the three months ended June 30, 2012:

Segments	Rental Revenues(1)		Resident Fees and Services		Interest Income		Investment Management Fee Income		Total Revenues		NOI(2)		Adjusted NOI(2) (Cash NOI)
Senior housing	$	113,387	$	35,569	$	527	$	—	$	149,483	$	125,516	$	113,936
Post-acute/skilled	134,353		—		427		—		134,780		134,188		116,517
Life science	72,545		—		—		1		72,546		58,990		55,735
Medical office	80,905		—		—		469		81,374		48,926		47,682
Hospital	21,970		—		262		—		22,232		21,033		20,509
Total	$	423,160	$	35,569	$	1,216	$	470	$	460,415	$	388,653	$	354,379

For the six months ended June 30, 2013:

Segments	Rental Revenues(1)		Resident Fees and Services		Interest Income		Investment Management Fee Income		Total Revenues		NOI(2)		Adjusted NOI(2) (Cash NOI)
Senior housing	$	299,157	$	74,481	$	5,207	$	—	$	378,845	$	325,110	$	291,398
Post-acute/skilled	273,623		—		21,014		—		294,637		272,323		236,286
Life science	148,557		—		—		2		148,559		121,335		114,605
Medical office	177,429		—		—		940		178,369		107,915		105,528
Hospital	30,990		—		312		—		31,302		29,135		40,389
Total	$	929,756	$	74,481	$	26,533	$	942	$	1,031,712	$	855,818	$	788,206

For the six months ended June 30, 2012:

Segments	Rental Revenues(1)		Resident Fees and Services		Interest Income		Investment Management Fee Income		Total Revenues		NOI(2)		Adjusted NOI(2) (Cash NOI)
Senior housing	$	226,692	$	71,748	$	809	$	—	$	299,249	$	253,386	$	228,393
Post-acute/skilled	268,026		—		707		—		268,733		267,661		229,365
Life science	144,375		—		—		2		144,377		117,936		114,838
Medical office	160,861		—		—		961		161,822		97,178		94,604
Hospital	40,647		—		519		—		41,166		38,779		37,702
Total	$	840,601	$	71,748	$	2,035	$	963	$	915,347	$	774,940	$	704,902

(1) Represents rental and related revenues, tenant recoveries and income from DFLs.

(2) NOI is a non-GAAP supplemental financial measure used to evaluate the operating performance of real estate. The Company defines NOI as rental and related revenues, including tenant recoveries, resident fees and services, and income from direct financing leases, less property level operating expenses. NOI excludes interest income, investment management fee income, interest expense, depreciation and amortization, general and administrative expenses, litigation settlement, impairments, impairment recoveries, other income, net, income taxes, equity income from and impairments of investments in unconsolidated joint ventures, and discontinued operations. The Company believes NOI provides relevant and useful information because it reflects only income and operating expense items that are incurred at the property level and presents them on an unleveraged basis. Adjusted NOI is calculated as NOI after eliminating the effects of straight-line rents, DFL accretion, amortization of above and below market lease intangibles, and lease termination fees. Adjusted NOI is sometimes referred to as “cash NOI.” The Company uses NOI and adjusted NOI to make decisions about resource allocations and to assess and compare property level performance. The Company believes that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP because it does not reflect the aforementioned excluded items. Further, the Company’s definition of NOI may not be comparable to the definition used by other REITs or real estate companies, as those companies may use different methodologies for calculating NOI.

Table of Contents

The following is a reconciliation of reported net income to NOI and adjusted NOI (in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Net income	$	216,725		$	204,975		$	450,509		$	401,539
Interest income	(14,147		)	(1,216		)	(26,533		)	(2,035		)
Investment management fee income	(499		)	(470		)	(942		)	(963		)
Interest expense	108,716			102,354			218,006			206,044
Depreciation and amortization	110,686			84,873			215,314			170,062
General and administrative	24,073			14,801			44,744			34,884
Other income, net	(3,240		)	(1,028		)	(15,303		)	(1,462		)
Income taxes	1,654			171			2,530			(541		)
Equity income from unconsolidated joint ventures	(15,585		)	(15,732		)	(30,386		)	(29,407		)
Total discontinued operations	(1,559		)	(75		)	(2,121		)	(3,181		)
NOI	426,824			388,653			855,818			774,940
Straight-line rents	2,838			(11,860		)	(15,955		)	(21,787		)
DFL accretion	(21,394		)	(22,017		)	(45,564		)	(47,639		)
Amortization of above and below market lease intangibles, net	(5,990		)	(625		)	(6,068		)	(1,322		)
Lease termination fees	(15		)	(251		)	(15		)	(399		)
NOI adjustments related to discontinued operations	(4		)	479			(10		)	1,109
Adjusted NOI	$	402,259		$	354,379		$	788,206		$	704,902

The Company’s total assets by segment were (in thousands):

	June 30,			December 31,
Segments	2013			2012
Senior housing	$	7,799,169		$	7,654,221
Post-acute/skilled nursing	6,389,017			6,080,826
Life science	3,955,373			3,932,397
Medical office	2,679,908			2,661,394
Hospital	733,338			711,836
Gross segment assets	21,556,805			21,040,674
Accumulated depreciation and amortization	(2,178,621		)	(1,970,621		)
Assets held-for-sale, net	6,936			9,578
Net segment assets	19,385,120			19,079,631
Other non-segment assets	666,673			835,924
Total assets	$	20,051,793		$	19,915,555

At June 30, 2013, goodwill of $50 million was allocated to segment assets as follows: (i) senior housing—$31 million, (ii) post-acute/skilled nursing—$3 million, (iii) medical office—$11 million, and (iv) hospital—$5 million.

Table of Contents

(14) Earnings Per Common Share

The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012
Numerator
Income from continuing operations	$	215,166		$	204,900		$	448,388		$	398,358
Noncontrolling interests’ share in continuing operations	(3,324		)	(2,951		)	(6,523		)	(6,135		)
Income from continuing operations applicable to HCP, Inc.	211,842			201,949			441,865			392,223
Preferred stock dividends	—			—			—			(17,006		)
Participating securities’ share in continuing operations	(378		)	(557		)	(856		)	(1,674		)
Income from continuing operations applicable to common shares	211,464			201,392			441,009			373,543
Discontinued operations	1,559			75			2,121			3,181
Net income applicable to common shares	$	213,023		$	201,467		$	443,130		$	376,724

Denominator
Basic weighted average common shares	454,618			420,468			454,137			415,243
Dilutive potential common shares	813			1,203			887			1,423
Diluted weighted average common shares	455,431			421,671			455,024			416,666

Basic earnings per common share
Income from continuing operations	$	0.47		$	0.48		$	0.97		$	0.90
Discontinued operations	—			—			0.01			0.01
Net income applicable to common shares	$	0.47		$	0.48		$	0.98		$	0.91

Diluted earnings per common share
Income from continuing operations	$	0.47		$	0.48		$	0.97		$	0.90
Discontinued operations	—			—			—			—
Net income applicable to common shares	$	0.47		$	0.48		$	0.97		$	0.90

Restricted stock and certain of the Company’s performance restricted stock units are considered participating securities, because dividend payments are not forfeited even if the underlying award does not vest, which require the use of the two-class method when computing basic and diluted earnings per share.

Options to purchase approximately 0.5 million and 1.0 million shares of common stock that had an exercise price (including deferred compensation expense) in excess of the average closing market price of the Company’s common stock during the three months ended June 30, 2013 and 2012, respectively, were not included in the Company’s earnings per share calculations because they are anti-dilutive. Restricted stock and performance restricted stock units representing 2,900 and 21,000 shares of common stock during the three months ended June 30, 2013 and 2012, respectively, were not included because they are anti-dilutive. Additionally, 6.0 million shares issuable upon conversion of 3.9 million DownREIT units during the three months ended June 30, 2013 were not included because they are anti-dilutive. During the three months ended June 30, 2012, 5.8 million shares issuable upon conversion of 4.1 million DownREIT units were not included because they are anti-dilutive.

(15) Supplemental Cash Flow Information

The following table provides supplemental cash flow information (in thousands):

	Six Months Ended June 30,
	2013		2012
Supplemental cash flow information:
Interest paid, net of capitalized interest	$	205,207	$	192,853
Income taxes paid	1,995		1,682
Capitalized interest	8,036		13,495
Supplemental schedule of non-cash investing activities:
Accrued construction costs	17,585		18,522

Table of Contents

	Six Months Ended June 30,
	2013		2012
Supplemental schedule of non-cash financing activities:
Vesting of restricted stock units	103		378
Cancellation of restricted stock	(16	)	(4	)
Conversion of non-managing member units into common stock	2,912		2,273
Mortgages and other liabilities assumed with real estate acquisitions	12,728		—
Unrealized gains (losses) on available-for-sale securities and derivatives designated as cash flow hedges, net	10,700		(437	)

See additional information regarding supplemental non-cash financing activities related to the preferred stock redemption in Note 12.

(16) Variable Interest Entities

Unconsolidated Variable Interest Entities

At June 30, 2013, the Company leased 48 properties to a total of seven VIE tenants and had an additional investment in a loan to a VIE borrower. The Company has determined that it is not the primary beneficiary of these VIEs. The carrying value and classification of the related assets, liabilities and maximum exposure to loss as a result of the Company’s involvement with these VIEs are presented below at June 30, 2013 (in thousands):

VIE Type	Maximum Loss Exposure(1)		Asset/Liability Type	Carrying Amount
VIE tenants—operating leases	$	274,078	Lease intangibles, net and straight-line rent receivables	$	14,704
VIE tenants—DFLs	1,102,212		Net investment in DFLs	602,766
Loan—senior secured	29,151		Loans receivable, net	29,151
Loan—subordinated secured	164,579		Loans receivable, net	164,579
Debt investment	16,897		Marketable debt securities	16,897

(1) The Company’s maximum loss exposure related to the VIE tenants represents the future minimum lease payments over the remaining term of the respective leases, which may be mitigated by re-leasing the properties to new tenants. The Company’s maximum loss exposure related to its loans and marketable debt securities to the VIEs represents its current aggregate carrying amount.

As of June 30, 2013, the Company has not provided, and is not required to provide, financial support through a liquidity arrangement or otherwise, to its unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash shortfalls).

The Company holds an interest-only, senior secured term loan made to a borrower (Delphis Operations, L.P.) that has been identified as a VIE (see Note 6 for additional information on the Delphis loan). The Company does not consolidate the VIE because it does not have the ability to control the activities that most significantly impact the VIE’s economic performance. The loan is collateralized by all of the assets of the borrower (comprised primarily of interests in partnerships that operate surgical facilities, some of which are on the premises of properties owned by the Company or HCP Ventures IV, LLC) and is supported in part by limited guarantees made by certain former and current principals of the borrower. Recourse under certain of these guarantees is limited to the guarantors’ respective ownership interests in certain entities owning real estate that are pledged to secure such guarantees.

The Company holds a subordinated loan made to a borrower (Barchester) that has been identified as a VIE (see Note 6 for additional information on the Barchester loan). The Company does not consolidate the VIE because it does not have the ability to control the activities that most significantly impact the VIE’s economic performance. The loan is collateralized by the borrower’s interests in real estate.

The Company holds commercial mortgage-backed securities (“CMBS”) issued by Federal Home Loan Mortgage Corporation (“Freddie MAC”) through a special purpose entity that has been identified as a VIE. The Company does not consolidate the VIE because it does not have the ability to control the activities that most significantly impact the VIE’s economic performance. The CMBS issued by the VIE are backed by mortgages on senior housing facilities.

See Notes 5 and 6 for additional descriptions of the nature, purpose and activities of the Company’s unconsolidated VIEs and interests therein.

Table of Contents

Consolidated Variable Interest Entities

In September 2011, the Company formed a partnership in which it has a 90% ownership interest in a joint venture entity that owns and operates 21 properties in a RIDEA structure (“RIDEA Entity”). The Company consolidated the RIDEA Entity as a result of the rights it acquired through the joint venture agreement with Brookdale. In the fourth quarter of 2012, upon the occurrence of a reconsideration event, it was determined that this RIDEA Entity was a VIE and that the Company is the primary beneficiary; therefore, the Company continued to consolidate this entity. During the second quarter of 2013, upon the occurrence of a reconsideration event, it was determined that this RIDEA Entity was no longer a VIE; however, the Company continues to consolidate the RIDEA Entity. The assets and liabilities of this RIDEA Entity substantially consist of cash and cash equivalents, accounts receivable, and accounts payable and accrued liabilities generated from its operating activities. The assets generated by the operating activities of the RIDEA Entity may be used to settle its contractual obligations, which include lease obligations to the Company. The Company is entitled to its ownership share of the RIDEA Entity’s assets; however, it does not guarantee its liabilities (or contractual obligations) and is not liable to its general creditors.

(17) Fair Value Measurements

The following table illustrates the Company’s financial assets and liabilities measured at fair value on a recurring basis in the condensed consolidated balance sheets. Recognized gains and losses are recorded in other income, net on the Company’s condensed consolidated statements of income. During the six months ended June 30, 2013, there were no transfers of financial assets or liabilities within the fair value hierarchy.

The financial assets and liabilities carried at fair value on a recurring basis at June 30, 2013 follow (in thousands):

Financial Instrument	Fair Value			Level 2			Level 3
Currency swap asset(1)	$	2,218		$	2,218		$	—
Interest-rate swap assets (1)	1,487			1,487			—
Interest-rate swap liabilities (1)	(9,610		)	(9,610		)	—
Warrants(1)	452			—			452
	$	(5,453	)	$	(5,905	)	$	452

(1) Interest rate and currency swaps as well as common stock warrant fair values are determined based on observable and unobservable market assumptions utilizing standardized derivative pricing models.

Table of Contents

(18) Disclosures About Fair Value of Financial Instruments

The carrying values of cash and cash equivalents, restricted cash, accounts receivable, accounts payable and accrued liabilities are reasonable estimates of fair value because of the short-term maturities of these instruments. The fair values of loans receivable, bank line of credit, term loan, mortgage debt and other debt are based on rates currently prevailing for similar instruments with similar maturities. The fair values of the marketable debt securities, interest-rate and currency swap contracts as well as common stock warrants are determined based on observable and unobservable market assumptions using standardized pricing models. The fair values of the senior unsecured notes and marketable equity securities are determined utilizing market quotes.

The table below summarizes the carrying values and fair values of the Company’s financial instruments (in thousands):

	June 30, 2013				December 31, 2012
	Carrying Value		Fair Value		Carrying Value		Fair Value
Loans receivable, net(2)	$	555,791	$	567,280	$	276,030	$	279,850
Marketable debt securities(3)	225,285		255,961		222,809		234,137
Marketable equity securities(1)	—		—		24,829		24,829
Warrants(3)	452		452		670		670
Bank line of credit(2)	261,582		261,582		—		—
Term loan(2)	208,418		208,418		222,694		222,694
Senior unsecured notes(1)	6,564,842		7,003,556		6,712,624		7,432,012
Mortgage debt(2)	1,653,426		1,696,918		1,676,544		1,771,155
Other debt(2)	78,633		78,633		81,958		81,958
Interest-rate swap assets(2)	1,487		1,487		89		89
Interest-rate swap liabilities(2)	9,610		9,610		12,699		12,699
Currency swap asset(2)	2,218		2,218		—		—
Currency swap liabilities(2)	—		—		2,641		2,641

(1) Level 1: Fair value calculated based on quoted prices in active markets.

(2) Level 2: Fair value based on quoted prices for similar or identical instruments in active or inactive markets, respectively, or calculated utilizing model derived valuations in which significant inputs or value drivers are observable in active markets.

(3) Level 3: Fair value determined based on significant unobservable market inputs using standardized derivative pricing models.

(19) Derivative Financial Instruments

The following table summarizes the Company’s outstanding interest-rate and foreign currency swap contracts as of June 30, 2013 (dollars and GBP in thousands):

Date Entered	Maturity Date	Hedge Designation	Fixed Rate/Buy Amount			Floating/Exchange Rate Index	Notional/ Sell Amount		Fair Value(1)
July 2005(2)	July 2020	Cash Flow	3.82		%	BMA Swap Index	$	45,600	$	(6,496	)
November 2008(3)	October 2016	Cash Flow	5.95		%	1 Month LIBOR+1.50%	$	26,700	$	(3,113	)
July 2009(4)	July 2013	Cash Flow	6.13		%	1 Month LIBOR+3.65%	$	13,500	$	(1	)
July 2012(4)	June 2016	Cash Flow	1.81		%	1 Month GBP LIBOR+1.20%	£	137,000	$	1,487
July 2012(5)	June 2016	Cash Flow	$	68,200		Buy USD/Sell GBP	£	43,500	$	2,218

(1) Interest-rate and foreign currency swap assets are recorded in other assets, net and interest-rate and foreign currency swap liabilities are recorded in accounts payable and accrued liabilities on the condensed consolidated balance sheets.

(2) Represents three interest-rate swap contracts with an aggregate notional amount of $45.6 million which hedge fluctuations in interest payments on variable-rate secured debt due to overall changes in hedged cash flows.

(3) Acquired in conjunction with mortgage debt assumed related to real estate acquired on December 28, 2010. Hedges fluctuations in interest payments on variable-rate secured debt due to fluctuations in the underlying benchmark interest rate.

(4) Hedges fluctuations in interest payments on variable-rate secured and unsecured debt due to fluctuations in the underlying benchmark interest rate.

(5) Currency swap contract (buy USD/sell GBP) hedges the foreign currency exchange risk related to a portion of the Company’s forecasted interest receipts on GBP denominated senior unsecured notes. Represents six foreign exchange contracts to sell £7.2 million at a rate of 1.5695 on various dates between December 2013 and June 2016.

Table of Contents

The Company uses derivative instruments to mitigate the effects of interest rate and foreign currency fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. The Company does not use derivative instruments for speculative or trading purposes.

The primary risks associated with derivative instruments are market and credit risk. Market risk is defined as the potential for loss in value of a derivative instrument due to adverse changes in market prices. Utilizing derivative instruments allows the Company to manage the risk of fluctuations in interest and foreign currency rates related to the potential impact these changes could have on future earnings, forecasted cash flows and the fair value of recognized obligations.

Credit risk is the risk that one of the parties to a derivative contract fails to perform or meet their financial obligation. The Company does not obtain collateral associated with its derivative contracts, but monitors the credit standing of its counterparties on a regular basis. Should a counterparty fail to perform, the Company would incur a financial loss to the extent that the associated derivative contract was in an asset position. At June 30, 2013, the Company does not anticipate non-performance by the counterparties to its outstanding derivative contracts.

On July 27, 2012, the Company entered into foreign currency swap contracts to hedge the foreign currency exchange risk related to a portion of the forecasted interest receipts from its GBP denominated senior unsecured notes (see additional discussion of the Four Seasons senior unsecured notes in Note 9). The cash flow hedge has a fixed USD/GBP exchange rate of 1.5695 (buy $11.4 million and sell £7.2 million semi-annually) for a portion of its forecasted semi-annual cash receipts denominated in GBP. The foreign currency swap contracts mature through June 2016 (the end of the non-call period of the senior unsecured notes). The fair value of the contracts at June 30, 2013 was $2.2 million and is included in other assets, net. During the six months ended June 30, 2013, there was no ineffective portion related to this hedge.

On July 27, 2012, the Company entered into an interest-rate swap contract that is designated as hedging the interest payments on its GBP denominated Term Loan due to fluctuations in the underlying benchmark interest rate (see additional discussion of the Term Loan in Note 10). The cash flow hedge has a notional amount of £137 million and expires in June 2016 (the maturity of the Term Loan). The fair value of the contract at June 30, 2013 was $1.5 million and is included in other assets, net. During the six months ended June 30, 2013, there was no ineffective portion related to this hedge.

At June 30, 2013, the Company expects that the hedged forecasted transactions for each of the outstanding qualifying cash flow hedging relationships remain probable of occurring and as a result no gains or losses recorded to accumulated other comprehensive loss are expected to be reclassified to earnings.

To illustrate the effect of movements in the interest rate and foreign currency markets, the Company performed a market sensitivity analysis on its outstanding hedging instruments. The Company applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the instruments’ change in fair value. The following table summarizes the results of the analysis performed (dollars in thousands):

		Effects of Change in Interest and Foreign Currency Rates
Date Entered	Maturity Date	+50 Basis Points			-50 Basis Points			+100 Basis Points			-100 Basis Points
July 2005	July 2020	$	1,512		$	(1,490	)	$	3,013		$	(2,991	)
November 2008	October 2016	439			(411		)	864			(836		)
July 2009	July 2013	(1		)	(2		)	(1		)	(3		)
July 2012 (interest-rate swap)	June 2016	2,898			(3,209		)	5,951			(6,263		)
July 2012 (foreign currency swap)	June 2016	(459		)	202			(790		)	532

Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Cautionary Language Regarding Forward-Looking Statements

Statements in this Quarterly Report on Form 10-Q that are not historical factual statements are “forward-looking statements.” We intend to have our forward-looking statements covered by the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with those provisions. Forward-looking statements include, among other things, statements regarding our and our officers’ intent, belief or expectation as identified by the use of words such as “may,” “will,” “project,” “expect,” “believe,” “intend,” “anticipate,” “seek,” “forecast,” “plan,” “estimate,” “could,” “would,” “should” and other comparable and derivative terms or the negatives thereof. In addition, we, through our officers, from time to time, make forward-looking oral and written public statements concerning our expected future operations, strategies, securities offerings, growth and investment opportunities, dispositions, capital structure changes, budgets and other developments. Readers are cautioned that, while forward-looking statements reflect our good faith belief and reasonable assumptions based upon current information, we can give no assurance that our expectations or forecasts will be attained. Therefore, readers should be mindful that forward-looking statements are not guarantees of future performance and that they are subject to known and unknown risks and uncertainties that are difficult to predict. As more fully set forth under “Part I, Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, factors that may cause our actual results to differ materially from the expectations contained in the forward-looking statements include:

(a) Changes in global, national and local economic conditions, including a prolonged period of weak economic growth;

(b) Volatility in the capital markets, including changes in interest rates and the availability and cost of capital;

(d) The effect on healthcare providers of the automatic spending cuts enacted by Congress (“Sequestration”) on entitlement programs, including Medicare, will, unless modified, result in future reductions in reimbursements;

(e) The ability of our operators, tenants and borrowers to conduct their respective businesses in a manner sufficient to maintain or increase their revenues and to generate sufficient income to make rent and loan payments to us and our ability to recover investments made, if applicable, in their operations;

(f) The financial weakness of some operators and tenants, including potential bankruptcies and downturns in their businesses, which results in uncertainties regarding our ability to continue to realize the full benefit of such operators’ and/or tenants’ leases;

(g) Changes in federal, state or local laws and regulations, including those affecting the healthcare industry that affect our costs of compliance or increase the costs, or otherwise affect the operations of our operators, tenants and borrowers;

(h) The potential impact of future litigation matters, including the possibility of larger than expected litigation costs, adverse results and related developments;

(i) Competition for tenants and borrowers, including with respect to new leases and mortgages and the renewal or rollover of existing leases;

(j) Our ability to negotiate the same or better terms with new tenants or operators if existing leases are not renewed or we exercise our right to replace an existing operator or tenant upon default;

(k) Availability of suitable properties to acquire at favorable prices and the competition for the acquisition and financing of those properties;

(l) The financial, legal, regulatory and reputational difficulties of significant operators of our properties;

(m) The risk that we may not be able to achieve the benefits of investments within expected time-frames or at all, or within expected cost projections;

(n) The ability to obtain financing necessary to consummate acquisitions on favorable terms;

Table of Contents

(o) The risks associated with our investments in joint ventures and unconsolidated entities, including our lack of sole decision making authority and our reliance on our joint venture partners’ financial condition and continued cooperation; and

(p) Changes in the credit ratings on U.S. government debt securities or default or delay in payment by the United States of its obligations.

Except as required by law, we undertake no, and hereby disclaim any, obligation to update any forward-looking statements, whether as a result of new information, changed circumstances or otherwise.

The information set forth in this Item 2 is intended to provide readers with an understanding of our financial condition, changes in financial condition and results of operations. We will discuss and provide our analysis in the following order:

· Executive Summary

· 2013 Transaction Overview

· Dividends

· Critical Accounting Policies

· Results of Operations

· Liquidity and Capital Resources

· Funds from Operations (“FFO”)

· Off-Balance Sheet Arrangements

· Contractual Obligations

· Inflation

· Recent Accounting Pronouncements

Executive Summary

We are a Maryland corporation and were organized to qualify as a self-administered real estate investment trust (“REIT”) that, together with our unconsolidated joint ventures, invests primarily in real estate serving the healthcare industry in the United States (“U.S.”). We acquire, develop, lease, manage and dispose of healthcare real estate, and provide financing to healthcare providers. At June 30, 2013, our portfolio of investments, including properties in our Investment Management Platform, consisted of interests in 1,164 facilities. Our Investment Management Platform represents the following joint ventures: (i) HCP Ventures III, LLC, (ii) HCP Ventures IV, LLC and (iii) the HCP Life Science ventures.

Our business strategy is based on three principles: (i) opportunistic investing, (ii) portfolio diversification and (iii) conservative financing. We actively redeploy capital from investments with lower return potential or shorter investment horizons into assets representing longer term investments with attractive risk-adjusted return potential. We make investments where the expected risk-adjusted return exceeds our cost of capital and strive to capitalize on our operator, tenant and other business relationships to grow our business.

Our strategy contemplates acquiring and developing properties on terms that are favorable to us. Generally, we prefer larger, more complex private transactions that leverage our management team’s experience and our infrastructure. We follow a disciplined approach to enhancing the value of our existing portfolio, including ongoing evaluation of potential disposition of properties that no longer fit our strategy.

We primarily generate revenue by leasing healthcare properties under long-term leases with fixed and/or inflation indexed escalators. Most of our rents and other earned income from leases are received under triple-net leases or leases that provide for substantial recovery of operating expenses; however, some of our medical office and life science leases are structured as gross or modified gross leases. Operating expenses are generally related to medical office building (“MOB”) and life science leased properties and senior housing properties managed on our behalf (“RIDEA properties”). Accordingly, for such MOBs, life science facilities and RIDEA properties, we incur certain property operating expenses, such as real estate taxes, repairs and maintenance, property management fees, utilities, employee costs for resident care and insurance. Our growth for these assets depends, in part, on our ability to (i) increase rental income and other earned income from leases by increasing rental rates and occupancy levels; (ii) maximize tenant recoveries given underlying lease structures; and (iii) control operating and other expenses. Our operations are impacted by property specific, market specific, general economic and other conditions.

Table of Contents

2013 Transaction Overview

Investment Transactions

During the six months ended June 30, 2013, we made investments of $463 million, which included the following:

· We acquired the four remaining senior housing facilities from our previously announced Blackstone JV Acquisition for $38 million.

· On May 2, 2013, we acquired £121 million of debt investment at a discount for £109 million ($170 million). This investment earns cash interest at London Interbank Offered Rate (“LIBOR”) plus a weighted-average margin of 3.14% and is secured by an interest in 160 healthcare facilities leased and operated by Barchester Healthcare (“Barchester”). Founded in 1992, Barchester is the operator of over 200 care homes throughout the United Kingdom with over 10,000 residents and approximately 17,000 employees.

· On June 25, 2013, we funded the $102 million second tranche of our 2012 mezzanine loan facility to Tandem Health Care, an affiliate of Formation Capital, as part of the recapitalization of a post-acute/skilled nursing portfolio. The funds from the second tranche were used to repay debt senior to our loan. The loan bears interest at a fixed rate of 12% and 14% per annum for the first and second tranche, respectively. The facility will have a total term of up to 63 months from the initial closing in July 2012. The mezzanine loan facility is subordinate to $444 million of senior mortgage debt.

· We funded $153 million to acquire a senior housing facility, marketable debt securities, construction and other capital projects, primarily in our life science, medical office and senior housing segments.

During the six months ended June 30, 2013, we placed into service a 70,000 square foot building located in Mountain View, California that is 100% leased.

Financing Activities

On February 28, 2013, we repaid $150 million of maturing 5.625% senior unsecured notes.

Dividends

On July 25, 2013, we announced that our Board declared a quarterly common stock cash dividend of $0.525 per share. The common stock dividend will be paid on August 20, 2013 to stockholders of record as of the close of business on August 5, 2013 and represents an annualized dividend pay rate of $2.10 per share.

Critical Accounting Policies

The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires our management to use judgment in the application of accounting policies, including making estimates and assumptions. We base estimates on the best information available to us at the time, our experience and on various other assumptions believed to be reasonable under the circumstances. These estimates affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting periods. If our judgment or interpretation of the facts and circumstances relating to various transactions or other matters had been different, it is possible that different accounting would have been applied, resulting in a different presentation of our condensed consolidated financial statements. From time to time, we re-evaluate our estimates and assumptions. In the event estimates or assumptions prove to be different from actual results, adjustments are made in subsequent periods to reflect more current estimates and assumptions about matters that are inherently uncertain. A summary of our critical accounting policies is included in our Annual Report on Form 10-K for the year ended December 31, 2012 in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”; our critical accounting policies have not changed during 2013.

Table of Contents

Results of Operations

We evaluate our business and allocate resources among our five business segments: (i) senior housing, (ii) post-acute/skilled nursing, (iii) life science, (iv) medical office and (v) hospital. Under the senior housing, life science, post-acute/skilled nursing and hospital segments, we invest or co-invest primarily in single operator or tenant properties, through the acquisition and development of real estate, management of operations and by debt issued by operators in these sectors. Under the medical office segment, we invest or co-invest through the acquisition and development of MOBs that are leased under gross, modified gross or triple-net leases, generally to multiple tenants, and which generally require a greater level of property management.

We use net operating income from continuing operations (“NOI”) and adjusted NOI to assess and compare property level performance, including our same property portfolio (“SPP”), and to make decisions about resource allocations. We believe these measures provide investors relevant and useful information because they reflect only income and operating expense items that are incurred at the property level and present them on an unleveraged basis. We believe that net income is the most directly comparable GAAP measure to NOI. NOI should not be viewed as an alternative measure of operating performance to net income as defined by GAAP since NOI excludes certain components from net income. Further, NOI may not be comparable to that of other REITs or real estate companies, as they may use different methodologies for calculating NOI. See Note 13 to the Condensed Consolidated Financial Statements for additional segment information and the relevant reconciliations from net income to NOI and adjusted NOI.

Operating expenses are generally related to MOB and life science leased properties and senior housing properties managed on our behalf (RIDEA properties). We generally recover all or a portion of MOB and life science expenses from the tenants (tenant recoveries). The presentation of expenses as operating or general and administrative is based on the underlying nature of the expense. Periodically, we review the classification of expenses between categories and make revisions based on changes in the underlying nature of the expenses.

Our evaluation of results of operations by each business segment includes an analysis of our SPP and our total property portfolio. SPP information allows us to evaluate the performance of our leased property portfolio under a consistent population by eliminating changes in the composition of our portfolio of properties. We identify our SPP as stabilized properties that remained in operations and were consistently reported as leased properties or RIDEA properties for the duration of the year-over-year comparison periods presented. Accordingly, it takes a stabilized property a minimum of 12 months in operations under a consistent reporting structure to be included in our SPP. Newly acquired operating assets are generally considered stabilized at the earlier of lease-up (typically when the tenant(s) controls the physical use of at least 80% of the space) or 12 months from the acquisition date. Newly completed developments, including redevelopments, are considered stabilized at the earlier of lease-up or 24 months from the date the property is placed in service. SPP NOI excludes certain non-property specific operating expenses that are allocated to each operating segment on a consolidated basis.

Comparison of the Three Months Ended June 30, 2013 to the Three Months Ended June 30, 2012

During the fourth quarter of 2012 and first quarter of 2013, we acquired a portfolio of 133 senior housing communities (the “Blackstone JV Acquisition”; see additional information in Note 3 to the Condensed Consolidated Financial Statements). The transaction closed in two stages: (i) 129 senior housing facilities during the fourth quarter of 2012 for $1.7 billion; and (ii) four senior housing facilities during the first quarter of 2013 for $38 million. The results of operations from the acquisitions are reflected in our condensed consolidated financial statements from those respective dates.

Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our five business segments. Our consolidated SPP consists of 925 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2012 and that remained in operations under a consistent reporting structure through June 30, 2013. Our consolidated total property portfolio represents 1,090 and 933 properties at June 30, 2013 and 2012, respectively, and excludes properties classified as discontinued operations.

Table of Contents

Results are as of and for the three months ended June 30, 2013 and 2012 (dollars and square feet in thousands except per capacity data):

Senior Housing

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental revenues(1)	$	115,941		$	113,387		$	2,554		$	150,261		$	113,387		$	36,874
Resident fees and services	37,590			35,569			2,021			37,590			35,569			2,021
Total revenues	153,531			148,956			4,575			187,851			148,956			38,895
Operating expenses	(23,407		)	(22,804		)	(603		)	(24,137		)	(23,440		)	(697		)
NOI	130,124			126,152			3,972			163,714			125,516			38,198
Straight-line rents	(3,120		)	(6,786		)	3,666			(10,388		)	(6,786		)	(3,602		)
DFL accretion	(4,731		)	(4,436		)	(295		)	(4,731		)	(4,436		)	(295		)
Amortization of above and below market lease intangibles, net	(324		)	(358		)	34			(195		)	(358		)	163
Adjusted NOI	$	121,949		$	114,572		$	7,377		$	148,400		$	113,936		$	34,464
Adjusted NOI % change							6.4		%

Property count(2)	311			311						445			311
Average capacity (units)(3)	35,307			35,309						45,640			35,309
Average annual rent per unit(4)	$	13,836		$	12,984					$	13,086		$	12,984

(1) Represents rental and related revenues and income from direct financing leases (“DFLs”).

(2) From our past presentation of SPP for the three months ended June 30, 2012, we removed three senior housing properties from SPP that were sold or classified as held for sale.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit includes operating income from properties under a RIDEA structure that are based on NOI.

SPP NOI and Adjusted NOI. SPP NOI increased primarily as a result of rent increases related to new leases or leases not subject to straight-line rents. SPP adjusted NOI improved primarily as a result of annual rent increases, an increase in rental revenues from properties that were previously transitioned from Sunrise to other operators and increased NOI from properties operated in a RIDEA structure.

Total Portfolio NOI and Adjusted NOI. Including the impact of our SPP, our total portfolio NOI and adjusted NOI primarily increased as a result of our Blackstone JV Acquisition.

Post-Acute/Skilled Nursing

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental revenues(1)	$	137,520		$	134,353		$	3,167		$	137,520		$	134,353		$	3,167
Operating expenses	(153		)	(165		)	12			(653		)	(165		)	(488		)
NOI	137,367			134,188			3,179			136,867			134,188			2,679
Straight-line rents	(88		)	(101		)	13			(88		)	(101		)	13
DFL accretion	(16,663		)	(17,581		)	918			(16,663		)	(17,581		)	918
Amortization of above and below market lease intangibles, net	12			11			1			12			11			1
Adjusted NOI	$	120,628		$	116,517		$	4,111		$	120,128		$	116,517		$	3,611
Adjusted NOI % change							3.5		%

Property count(2)	312			312						312			312
Average capacity (beds)(3)	39,826			39,830						39,826			39,830
Average annual rent per bed	$	12,130		$	11,717					$	12,130		$	11,717

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the three months ended June 30, 2012, we removed a post-acute/skilled nursing property from SPP that was sold or classified as held for sale.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

Table of Contents

NOI and Adjusted NOI. SPP and total portfolio NOI and adjusted NOI primarily increased as a result of annual rent escalations from 268 post-acute/skilled nursing facilities classified as DFLs from HCR ManorCare, Inc. (see Notes 5 and 11 to the Condensed Consolidated Financial Statements for additional information regarding the net investment in DFLs and HCR ManorCare, respectively).

Life Science

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental and related revenues	$	60,097		$	60,037		$	60		$	63,980		$	61,393		$	2,587
Tenant recoveries	10,696			11,044			(348		)	11,247			11,152			95
Total revenues	70,793			71,081			(288		)	75,227			72,545			2,682
Operating expenses	(12,329		)	(12,500		)	171			(13,839		)	(13,555		)	(284		)
NOI	58,464			58,581			(117		)	61,388			58,990			2,398
Straight-line rents	(2,943		)	(3,184		)	241			(3,203		)	(3,370		)	167
Amortization of above and below market lease intangibles, net	103			128			(25		)	93			115			(22		)
Lease termination fees	(13		)	—			(13		)	(13		)	—			(13		)
Adjusted NOI	$	55,611		$	55,525		$	86		$	58,265		$	55,735		$	2,530
Adjusted NOI % change							0.2		%

Property count	104			104						110			109
Average occupancy	91.6		%	89.9		%				91.6		%	89.2		%
Average occupied square feet	6,214			6,104						6,476			6,222
Average annual rent per occupied sq. ft.	$	44		$	45					$	45		$	45

Total Portfolio NOI and Adjusted NOI. Total portfolio NOI and adjusted NOI increased primarily as a result of an increase in life science occupancy, partially offset by mark-to-market rent reductions.

During the three months ended June 30, 2013, 78,000 square feet of new and renewal leases commenced at an average annual base rent of $23.53 per square foot compared to 67,000 square feet of expiring with an average annual base rent of $21.46 per square foot.

Medical Office

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental and related revenues	$	67,065		$	67,266		$	(201	)	$	76,903		$	69,072		$	7,831
Tenant recoveries	11,534			11,762			(228		)	13,271			11,833			1,438
Total revenues	78,599			79,028			(429		)	90,174			80,905			9,269
Operating expenses	(30,008		)	(29,861		)	(147		)	(35,218		)	(31,979		)	(3,239		)
NOI	48,591			49,167			(576		)	54,956			48,926			6,030
Straight-line rents	(689		)	(1,058		)	369			(1,332		)	(1,056		)	(276		)
Amortization of above and below market lease intangibles, net	115			61			54			235			63			172
Lease termination fees	(2		)	(251		)	249			(2		)	(251		)	249
Adjusted NOI	$	48,015		$	47,919		$	96		$	53,857		$	47,682		$	6,175
Adjusted NOI % change							0.2		%

Property count(1)	183			183						207			185
Average occupancy	90.4		%	91.1		%				90.2		%	90.9		%
Average occupied square feet	11,450			11,543						12,798			11,805
Average annual rent per occupied sq. ft.	$	27		$	27					$	28		$	27

(1) From our past presentation of SPP for the three months ended June 30, 2012, we removed two MOBs that were placed into redevelopment in 2012 and 2013, which no longer meet our criteria for SPP as of the date they were placed into redevelopment.

Table of Contents

Total Portfolio NOI and Adjusted NOI. Total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our MOB acquisitions during 2012.

During the three months ended June 30, 2013, 578,000 square feet of new and renewal leases commenced at an average annual base rent of $20.11 per square foot compared to 698,000 square feet of expiring and terminated leases with an average annual base rent of $19.18 per square foot.

Hospital

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental and related revenues	$	9,048		$	20,610		$	(11,562	)	$	10,238		$	21,374		$	(11,136	)
Tenant recoveries	628			596			32			628			596			32
Total revenues	9,676			21,206			(11,530		)	10,866			21,970			(11,104		)
Operating expenses	(967		)	(935		)	(32		)	(967		)	(937		)	(30		)
NOI	8,709			20,271			(11,562		)	9,899			21,033			(11,134		)
Straight-line rents	17,974			(163		)	18,137			17,844			(306		)	18,150
Amortization of above and below market lease intangibles, net	(6,108		)	(193		)	(5,915		)	(6,134		)	(218		)	(5,916		)
Adjusted NOI	$	20,575		$	19,915		$	660		$	21,609		$	20,509		$	1,100
Adjusted NOI % change							3.3		%

Property count(1)	15			15						16			16
Average capacity (beds)(2)	2,271			2,271						2,298			2,302
Average annual rent per bed	$	37,943		$	36,724					$	39,297		$	37,265

(1) From our past presentation of SPP for the three months ended June 30, 2012, we removed a hospital from SPP that was sold or classified as held for sale.

(2) Represents capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented. Certain operators in our hospital portfolio are not required under their respective leases to provide operational data.

SPP and Total Portfolio NOI. SPP and total portfolio NOI primarily decreased due to a net $12 million correction reducing previously recognized straight-line rents and increasing amortization of below market lease intangibles related to our Medical City Dallas hospital.

Other Income and Expense Items

Interest income

Interest income increased $13 million to $14 million for the three months ended June 30, 2013. The increase was primarily the result of interest income from our Four Seasons Health Care (“Four Seasons”) senior unsecured notes made in 2012, and the second tranche of our mezzanine loan facility to Tandem Health Care and Barchester loans made in 2013 (see Notes 9 and 6, respectively, to the Condensed Consolidated Financial Statements for additional information).

Interest expense

Interest expense increased $6 million to $109 million for the three months ended June 30, 2013. The increase was primarily a result of the following: (i) a decrease of capitalized interest related to assets that were under development in our life science and medical office segments and were placed in service during 2013 and 2012, (ii) our senior unsecured notes offerings during 2012, net of related maturities of certain senior unsecured notes during 2013 and 2012 and (iii) the origination of our term loan during 2012.

Our exposure to expense fluctuations related to our variable rate indebtedness is substantially mitigated by our interest rate swap contracts. For a more detailed discussion of our interest rate risk, see “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

Table of Contents

The table below sets forth information with respect to our debt, excluding premiums and discounts (dollars in thousands):

	As of June 30,(1)
	2013			2012
Balance:
Fixed rate	$	8,415,499		$	7,336,232
Variable rate	301,503			255,438
Total	$	8,717,002		$	7,591,670
Percent of total debt:
Fixed rate	97		%	97		%
Variable rate	3			3
Total	100		%	100		%
Weighted average interest rate at end of period:
Fixed rate	5.24		%	5.68		%
Variable rate	1.74		%	1.98		%
Total weighted average rate	5.12		%	5.56		%

(1) Excludes $79 million and $84 million at June 30, 2013 and 2012, respectively, of other debt that represents non-interest bearing life care bonds and occupancy fee deposits at certain of our senior housing facilities, which have no scheduled maturities. At June 30, 2013, $86 million of variable-rate mortgages and a £137 million ($208 million) term loan are presented as fixed-rate debt as the interest payments under such debt have been swapped (pay fixed and receive float). At June 30, 2012, $87 million of variable-rate mortgages are presented as fixed-rate debt as the interest payments under such debt have been swapped (pay fixed and receive float); the interest rates for swapped debt are presented at the swapped rates.

Depreciation and amortization expense

Depreciation and amortization expense increased $26 million to $111 million for the three months ended June 30, 2013. The increase was primarily the result of the impact of our Blackstone JV Acquisition and MOB acquisitions during 2012.

General and administrative expenses

General and administrative expenses increased $9 million to $24 million for the three months ended June 30, 2013. The increase was primarily the result of an insurance recovery of $7 million received in 2012 for previously incurred legal expenses and an increase in transaction costs incurred in 2013.

Other income, net

Other income, net increased $2 million to $3 million for the three months ended June 30, 2013. The increase was the result of a realized gain contingency related to a past portfolio acquisition.

Discontinued operations

During the three months ended June 30, 2013, we sold one property for $4 million, realizing a gain of $1 million.

Preferred stock dividends

On March 22, 2012, we announced the redemption of all outstanding shares of preferred stock. On April 23, 2012, the shares of our preferred stock were redeemed, plus all accrued and unpaid dividends to the redemption date. During the six months ended June 30, 2012, we incurred a redemption charge of $10.4 million related to the original issuance costs of the preferred stock (this charge is presented as an additional preferred stock dividend in our consolidated income statements).

Comparison of the Six Months Ended June 30, 2013 to the Six Months Ended June 30, 2012

During the fourth quarter of 2012 and first quarter of 2013, we acquired a portfolio of 133 senior housing communities (the “Blackstone JV Acquisition”, see additional information in Note 3 to the Condensed Consolidated Financial Statements). The transaction closed in two stages: (i) 129 senior housing facilities during the fourth quarter of 2012 for $1.7 billion; and (ii) four senior housing facilities during the first quarter of 2013 for $38 million. The results of operations from the acquisitions are reflected in our condensed consolidated financial statements from those respective dates.

Table of Contents

Segment NOI and Adjusted NOI

The tables below provide selected operating information for our SPP and total property portfolio for each of our five business segments. Our consolidated SPP consists of 922 properties representing properties acquired or placed in service and stabilized on or prior to January 1, 2012 and that remained in operations under a consistent reporting structure through June 30, 2013. Our consolidated total property portfolio represents 1,090 and 933 properties at June 30, 2013 and 2012, respectively, and excludes properties classified as discontinued operations.

Results are as of and for the six months ended June 30, 2013 and 2012 (dollars and square feet in thousands except per capacity data):

Senior Housing

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental revenues(1)	$	231,321		$	226,692		$	4,629		$	299,157		$	226,692		$	72,465
Resident fees and services	74,481			71,748			2,733			74,481			71,748			2,733
Total revenues	305,802			298,440			7,362			373,638			298,440			75,198
Operating expenses	(46,905		)	(43,768		)	(3,137		)	(48,528		)	(45,054		)	(3,474		)
NOI	258,897			254,672			4,225			325,110			253,386			71,724
Straight-line rents	(9,238		)	(14,692		)	5,454			(23,565		)	(14,692		)	(8,873		)
DFL accretion	(9,762		)	(9,585		)	(177		)	(9,762		)	(9,585		)	(177		)
Amortization of above and below market lease intangibles, net	(682		)	(716		)	34			(385		)	(716		)	331
Adjusted NOI	$	239,215		$	229,679		$	9,536		$	291,398		$	228,393		$	63,005
Adjusted NOI % change							4.2		%

Property count(2)	311			311						445			311
Average capacity (units)(3)	35,307			35,309						45,485			35,309
Average annual rent per unit(4)	$	13,570		$	13,025					$	12,900		$	13,025

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the six months ended June 30, 2012, we removed three senior housing properties from SPP that were sold or classified as held for sale.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

(4) Average annual rent per unit, includes operating income from properties under a RIDEA structure that are based on NOI.

Total Portfolio NOI and Adjusted NOI. Including the impact of our SPP, our total portfolio NOI and adjusted NOI primarily increased as a result of our Blackstone JV Acquisition.

Table of Contents

Post-Acute/Skilled Nursing

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental revenues(1)	$	273,623		$	268,026		$	5,597		$	273,623		$	268,026		$	5,597
Operating expenses	(299		)	(363		)	64			(1,300		)	(365		)	(935		)
NOI	273,324			267,663			5,661			272,323			267,661			4,662
Straight-line rents	(258		)	(265		)	7			(258		)	(265		)	7
DFL accretion	(35,802		)	(38,054		)	2,252			(35,802		)	(38,054		)	2,252
Amortization of above and below market lease intangibles, net	23			23			—			23			23			—
Adjusted NOI	$	237,287		$	229,367		$	7,920		$	236,286		$	229,365		$	6,921
Adjusted NOI % change							3.5		%
Property count(2)	312			312						312			312
Average capacity (beds)(3)	39,826			39,830						39,826			39,830
Average annual rent per bed	$	11,930		$	11,534					$	11,930		$	11,534

(1) Represents rental and related revenues and income from DFLs.

(2) From our past presentation of SPP for the six months ended June 30, 2012, we removed a post-acute/skilled nursing property from SPP that was sold or classified as held for sale.

(3) Represents average capacity as reported by the respective tenants or operators for the twelve-month period and a quarter in arrears from the periods presented.

Life Science

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental and related revenues	$	120,110		$	119,820		$	290		$	126,418		$	122,803		$	3,615
Tenant recoveries	21,173			21,295			(122		)	22,139			21,572			567
Total revenues	141,283			141,115			168			148,557			144,375			4,182
Operating expenses	(24,014		)	(24,038		)	24			(27,222		)	(26,439		)	(783		)
NOI	117,269			117,077			192			121,335			117,936			3,399
Straight-line rents	(6,270		)	(2,740		)	(3,530		)	(6,895		)	(3,290		)	(3,605		)
Amortization of above and below market lease intangibles, net	200			217			(17		)	178			192			(14		)
Lease termination fees	(13		)	—			(13		)	(13		)	—			(13		)
Adjusted NOI	$	111,186		$	114,554		$	(3,368	)	$	114,605		$	114,838		$	(233	)
Adjusted NOI % change							(2.9		)%

Property count	101			101						110			109
Average occupancy	92.7		%	91.0		%				91.5		%	89.1		%
Average occupied square feet	6,198			6,085						6,450			6,184
Average annual rent per occupied sq. ft.	$	44		$	46					$	44		$	46

Table of Contents

NOI and Adjusted NOI. SPP and total portfolio NOI increased primarily as a result of an increase in life science occupancy, partially offset by mark-to-market rent reductions. SPP and total portfolio adjusted NOI decreased primarily as a result of a $4 million rent payment received in February 2012 in connection with a lease amendment and mark-to-market rent reductions, partially offset by annual rent escalations and an increase in life science occupancy.

During the six months ended June 30, 2013, 261,000 square feet of new and renewal leases commenced at an average annual base rent of $30.30 per square foot compared to 172,000 square feet of expiring with an average annual base rent of $39.07 per square foot.

Medical Office

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental and related revenues	$	133,503		$	133,391		$	112		$	151,410		$	137,370		$	14,040
Tenant recoveries	22,765			23,307			(542		)	26,019			23,491			2,528
Total revenues	156,268			156,698			(430		)	177,429			160,861			16,568
Operating expenses	(59,454		)	(59,219		)	(235		)	(69,514		)	(63,683		)	(5,831		)
NOI	96,814			97,479			(665		)	107,915			97,178			10,737
Straight-line rents	(1,737		)	(2,373		)	636			(2,853		)	(2,416		)	(437		)
Amortization of above and below market lease intangibles, net	213			128			85			468			93			375
Lease termination fees	(2		)	(251		)	249			(2		)	(251		)	249
Adjusted NOI	$	95,288		$	94,983		$	305		$	105,528		$	94,604		$	10,924
Adjusted NOI % change							0.3		%

Property count(1)	183			183						207			185
Average occupancy	90.9		%	91.1		%				90.7		%	91.0		%
Average occupied square feet	11,521			11,525						12,856			11,825
Average annual rent per occupied sq. ft.	$	27		$	27					$	27		$	27

(1) From our past presentation of SPP for the six months ended June 30, 2012, we removed two MOBs that were placed into redevelopment in 2012 and 2013, which no longer meet our criteria for SPP as of the date they were placed into redevelopment.

Total Portfolio NOI and Adjusted NOI. Total portfolio NOI and adjusted NOI increased primarily as a result of the impact of our MOB acquisitions during 2012.

During the six months ended June 30, 2013, 917,000 square feet of new and renewal leases commenced at an average annual base rent of $21.68 per square foot compared to 1.3 million square feet of expiring and terminated leases with an average annual base rent of $21.52 per square foot.

Hospital

	SPP									Total Portfolio
	2013			2012			Change			2013			2012			Change
Rental and related revenues	$	27,470		$	37,952		$	(10,482	)	$	29,799		$	39,479		$	(9,680	)
Tenant recoveries	1,191			1,168			23			1,191			1,168			23
Total revenues	28,661			39,120			(10,459		)	30,990			40,647			(9,657		)
Operating expenses	(1,854		)	(1,865		)	11			(1,855		)	(1,868		)	13
NOI	26,807			37,255			(10,448		)	29,135			38,779			(9,644		)
Straight-line rents	17,878			(347		)	18,225			17,606			(641		)	18,247
Amortization of above and below market lease intangibles, net	(6,301		)	(385		)	(5,916		)	(6,352		)	(436		)	(5,916		)
Adjusted NOI	$	38,384		$	36,523		$	1,861		$	40,389		$	37,702		$	2,687
Adjusted NOI % change							5.1		%

Property count(1)	15			15						16			16
Average capacity (beds)(2)	2,271			2,271						2,298			2,302
Average annual rent per bed	$	35,436		$	33,807					$	36,766		$	34,379

(1) From our past presentation of SPP for the six months ended June 30, 2012, we removed a hospital from SPP that was sold or classified as held for sale.

Table of Contents

Other Income and Expense Items

Interest income

Interest income increased $24 million to $27 million for the six months ended June 30, 2013. The increase was primarily the result of interest income from our Four Seasons senior unsecured notes made in 2012, and the second tranche of our mezzanine loan facility to Tandem Health Care and Barchester loans made in 2013 (see Notes 9 and 6, respectively, to the Condensed Consolidated Financial Statements for additional information).

Interest expense

Interest expense increased $12 million to $218 million for the six months ended June 30, 2013. The increase was primarily a result of the following: (i) a decrease of capitalized interest related to assets that were under development in our life science and medical office segments and were placed in service during 2013 and 2012, (ii) our senior unsecured notes offerings during 2012, net of related maturities of certain senior unsecured notes during 2013 and 2012 and (iii) the origination of our term loan during 2012. These increases were partially offset by a decrease in the average outstanding balance under our revolving line of credit facility.

Depreciation and amortization expense

Depreciation and amortization expense increased $45 million to $215 million for the six months ended June 30, 2013. The increase was primarily the result of the impact of our Blackstone JV Acquisition and MOB acquisitions during 2012.

General and administrative expenses

General and administrative expenses increased $10 million to $45 million for the six months ended June 30, 2013. The increase was primarily the result of an insurance recovery of $7 million received in 2012 for previously incurred legal expenses and an increase in transaction costs during 2013.

Other income, net

Other income, net increased $14 million to $15 million for the six months ended June 30, 2013. The increase was primarily the result of gains from the sale of marketable equity securities during 2013 of $11 million.

Discontinued operations

During the six months ended June 30, 2013, we sold one property for $4 million, realizing a gain of $1 million. During the six months ended June 30, 2012, we sold one property for $7 million, realizing a gain of $3 million.

Preferred stock dividends

Table of Contents

Liquidity and Capital Resources

Our principal liquidity needs are to: (i) fund recurring operating expenses, (ii) meet debt service requirements including principal payments and maturities in the last six months of 2013, (iii) fund capital expenditures, including tenant improvements and leasing costs, (iv) fund acquisition and development activities, and (v) make dividend distributions. We anticipate that cash flow from continuing operations over the next 12 months will be adequate to fund our business operations, debt service payments, recurring capital expenditures and cash dividends to shareholders. Capital requirements relating to maturing indebtedness, acquisitions and development activities may require funding from borrowings and/or equity and debt offerings.

Access to capital markets impacts our cost of capital and ability to refinance maturing indebtedness, as well as our ability to fund future acquisitions and development through the issuance of additional securities or secured debt. Credit ratings impact our ability to access capital and directly impact our cost of capital as well. For example, as noted below, our revolving line of credit facility accrues interest at a rate per annum equal to LIBOR plus a margin that depends upon our debt ratings. We also pay a facility fee on the entire revolving commitment that depends upon our debt ratings. As of July 25, 2013, we had a credit rating of BBB+ from Fitch, Baa1 from Moody’s and BBB+ from S&P on our senior unsecured debt securities.

Net cash provided by operating activities was $572 million and $484 million for the six months ended June 30, 2013 and 2012, respectively. The increase in operating cash flows is primarily the result of the following: (i) the impact of our investments in 2012 and 2013, (ii) assets placed in service during 2012 and 2013 and (iii) rent escalations and resets in 2012 and 2013, which increases were partially offset by increased debt interest payments. Our cash flows from operations are dependent upon the occupancy level of multi-tenant buildings, rental rates on leases, our tenants’ performance on their lease obligations, the level of operating expenses and other factors.

The following are significant investing and financing activities for the six months ended June 30, 2013:

· made investments of $449 million (development and acquisition of real estate and funding of loans);

· sold marketable equity securities for $28 million;

· paid dividends on common stock of $477 million, which were generally funded by cash provided by our operating activities; and

· borrowed $265 million under our unsecured revolving line of credit facility to fund, among other things, the aforementioned investments and repaid $150 million of senior unsecured notes.

Debt

Bank Line of Credit and Term Loan

Our $1.5 billion unsecured revolving line of credit facility (the “Facility”) matures in March 2016 and contains a one-year extension option. Borrowings under this Facility accrue interest at LIBOR plus a margin that depends upon our debt ratings. We pay a facility fee on the entire revolving commitment that depends on our debt ratings. Based on our debt ratings at July 25, 2013, the margin on the Facility was 1.075%, and the facility fee was 0.175%. The Facility also includes a feature that will allow us to increase the borrowing capacity by an aggregate amount of up to $500 million, subject to securing additional commitments from existing lenders or new lending institutions. At June 30, 2013, we had $262 million (includes £109 million translated into U.S. dollars) outstanding under the Facility.

On July 30, 2012, we entered into a credit agreement with a syndicate of banks for a £137 million ($208 million at June 30, 2013) four-year unsecured Term Loan (the “Term Loan”) that accrues interest at a rate of GBP LIBOR plus 1.20%, based on our current debt ratings. Concurrent with the closing of the Term Loan, we entered into a four-year interest rate swap agreement that fixed the rate of the Term Loan at 1.81%, subject to adjustments based on our credit ratings. The Term Loan contains a one-year committed extension option.

The Facility and Term Loan contain certain financial restrictions and other customary requirements. Among other things, these covenants, using terms defined in the agreements, (i) limit the ratio of Consolidated Total Indebtedness to Consolidated Total Asset Value to 60%, (ii) limit the ratio of Secured Debt to Consolidated Total Asset Value to 30%, (iii) limit the ratio of Unsecured Debt to Consolidated Unencumbered Asset Value to 60%, (iv) require a minimum Fixed Charge Coverage ratio of 1.5 times and (v) require a formula-determined Minimum Consolidated Tangible Net Worth of $9.2 billion at June 30, 2013. At June 30, 2013, we were in compliance with each of these restrictions and requirements of the Facility and Term Loan.

Table of Contents

Our Facility also contains cross-default provisions to other indebtedness of ours, including in some instances, certain mortgages on our properties. Certain mortgages contain default provisions relating to defaults under the leases or operating agreements on the applicable properties by our operators or tenants, including default provisions relating to the bankruptcy filings of such operator or tenant. Although we believe that we would be able to secure amendments under the applicable agreements if a default as described above occurs, such a default may result in significantly less favorable borrowing terms than currently available, material delays in the availability of funding or other material adverse consequences.

Senior Unsecured Notes

At June 30, 2013, we had senior unsecured notes outstanding with an aggregate principal balance of $6.6 billion. Interest rates on the notes ranged from 1.24% to 6.98% with a weighted average effective interest rate of 5.10% and a weighted average maturity of six years at June 30, 2013. The senior unsecured notes contain certain covenants including limitations on debt, maintenance of unencumbered assets, cross-acceleration provisions and other customary terms. We believe we were in compliance with these covenants at June 30, 2013.

Mortgage Debt

At June 30, 2013, we had $1.7 billion in aggregate principal amount of mortgage debt outstanding that is secured by 138 healthcare facilities (including redevelopment properties) with a carrying value of $2.1 billion. Interest rates on the mortgage debt ranged from 0.69% to 8.69% with a weighted average effective interest rate of 6.12% and a weighted average maturity of three years at June 30, 2013.

Mortgage debt generally requires monthly principal and interest payments, is collateralized by certain properties and is generally non-recourse. Mortgage debt typically restricts transfer of the encumbered properties, prohibits additional liens, restricts prepayment, requires payment of real estate taxes, requires maintenance of the assets in good condition, requires maintenance of insurance on the assets and includes conditions to obtain lender consent to enter into and terminate material leases. Some of the mortgage debt is also cross-collateralized by multiple properties and may require tenants or operators to maintain compliance with the applicable leases or operating agreements of such real estate assets.

Other Debt

At June 30, 2013, we had $79 million of non-interest bearing life care bonds at two of our continuing care retirement communities and non-interest bearing occupancy fee deposits at two of our senior housing facilities, all of which were payable to certain residents of the facilities (collectively, “Life Care Bonds”). The Life Care Bonds are refundable to the residents upon the termination of the contract or upon the successful resale of the unit.

Debt Maturities

The following table summarizes our stated debt maturities and scheduled principal repayments at June 30, 2013 (in thousands):

Year	Amount(1)
2013 (Six months)	$	654,973
2014	667,221
2015	708,611
2016	1,661,941
2017	1,300,788
Thereafter	3,723,468
	8,717,002
(Discounts) and premiums, net	(28,734		)
	$	8,688,268

(1) Excludes $79 million of other debt that represents Life Care Bonds that have no scheduled maturities.

Table of Contents

Derivative Instruments

We use derivative instruments to mitigate the effects of interest rate and foreign exchange fluctuations on specific forecasted transactions as well as recognized financial obligations or assets. We do not use derivative instruments for speculative or trading purposes.

The following table summarizes our outstanding interest rate and foreign exchange swap contracts as of June 30, 2013 (dollars and GBP in thousands):

Date Entered	Maturity Date	Hedge Designation	Fixed Rate/Buy Amount			Floating/Exchange Rate Index	Notional/ Sell Amount		Fair Value
July 2005(1)	July 2020	Cash Flow	3.82		%	BMA Swap Index	$	45,600	$	(6,496	)
November 2008	October 2016	Cash Flow	5.95		%	1 Month LIBOR+1.50%	$	26,700	$	(3,113	)
July 2009	July 2013	Cash Flow	6.13		%	1 Month LIBOR+3.65%	$	13,500	$	(1	)
July 2012	June 2016	Cash Flow	1.81		%	1 Month GBP LIBOR+1.20%	£	137,000	$	1,487
July 2012	June 2016	Cash Flow	$	68,200		Buy USD/Sell GBP	£	43,500	$	2,218

For a more detailed description of our derivative instruments, see Note 19 to the Condensed Consolidated Financial Statements and “Quantitative and Qualitative Disclosures About Market Risk” in Item 3.

Equity

At June 30, 2013, we had 455 million shares of common stock outstanding. At June 30, 2013, equity totaled $11 billion, and our equity securities had a market value of $21 billion.

At June 30, 2013, there were a total of four million DownREIT units outstanding in four limited liability companies in which we are the managing member. The DownREIT units are exchangeable for an amount of cash approximating the then-current market value of shares of our common stock or, at our option, shares of our common stock (subject to certain adjustments, such as stock splits and reclassifications).

Shelf Registration

We have a prospectus that we filed with the U.S. Securities and Exchange Commission (the “SEC”) as part of a registration statement on Form S-3ASR, using a shelf registration process which expires in July 2015. Under the “shelf” process, we may sell any combination of the securities in one or more offerings. The securities described in the prospectus include common stock, preferred stock, depositary shares, debt securities and warrants.

The prospectus only provides a general description of the securities we may offer. The prospectus may not be used to sell securities unless accompanied by a prospectus supplement or a free writing prospectus. Each time we sell securities under the shelf registration, we will provide a prospectus supplement that will contain specific information about the terms of the securities being offered and of the offering. The prospectus supplement may also add, update or change information contained in the prospectus.

We may offer and sell the securities pursuant to the prospectus through underwriters, dealers or agents or directly to purchasers, on a continuous or delayed basis. The securities may also be resold by selling security holders. The prospectus supplement for each offering will describe in detail the plan of distribution for that offering and will set forth the names of any underwriters, dealers or agents involved in the offering and any applicable fees, commissions or discount arrangements. We intend to use the net proceeds from the sales of the securities as set forth in the applicable prospectus supplement, and unless otherwise set forth in a therein, we will not receive any proceeds if the securities are sold by a selling security holder.

Table of Contents

Funds From Operations (“FFO”)

We believe FFO applicable to common shares, diluted FFO applicable to common shares, and basic and diluted FFO per common share are important supplemental non-GAAP measures of operating performance for a REIT. Because the historical cost accounting convention used for real estate assets utilizes straight-line depreciation (except on land), such accounting presentation implies that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen and fallen with market conditions, presentations of operating results for a REIT that uses historical cost accounting for depreciation could be less informative. The term FFO was designed by the REIT industry to address this issue.

FFO is defined as net income applicable to common shares (computed in accordance with GAAP), excluding gains or losses from acquisition and dispositions of depreciable real estate or related interests, impairments of, or related to, depreciable real estate, plus real estate and DFL depreciation and amortization, with adjustments for joint ventures. Adjustments for joint ventures are calculated to reflect FFO on the same basis. FFO does not represent cash generated from operating activities in accordance with GAAP, is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income. We compute FFO in accordance with the current National Association of Real Estate Investment Trusts’ (“NAREIT”) definition; however, other REITs may report FFO differently or have a different interpretation of the current NAREIT definition from us. In addition, we present FFO before the impact of litigation settlement charges, preferred stock redemption charges, impairments (recoveries) of non-depreciable assets and merger-related items (defined below) (“FFO as adjusted”). Management believes FFO as adjusted is a useful alternative measurement. This measure is a modification of the NAREIT definition of FFO and should not be used as an alternative to net income (determined in accordance with GAAP).

Details of certain items that affect comparability are discussed under “Results of Operations” above. The following is a reconciliation of net income applicable to common shares, the most direct comparable financial measure calculated and presented in accordance with GAAP, to FFO and FFO as adjusted (in thousands, except per share data):

	Three Months Ended June 30,						Six Months Ended June 30,
	2013			2012			2013			2012

Net income applicable to common shares	$	213,023		$	201,467		$	443,130		$	376,724
Depreciation and amortization of real estate, in-place lease and other intangibles:
Continuing operations	110,686			84,873			215,314			170,062
Discontinued operations	81			3,051			170			6,138
DFL depreciation	3,529			3,142			6,958			6,192
Gain on sales of real estate	(887		)	—			(887		)	(2,856		)
Equity income from unconsolidated joint ventures	(15,585		)	(15,732		)	(30,386		)	(29,407		)
FFO from unconsolidated joint ventures	18,356			18,275			35,897			34,452
Noncontrolling interests’ and participating securities’ share in earnings	3,702			3,508			7,379			7,809
Noncontrolling interests’ and participating securities’ share in FFO	(5,255		)	(4,963		)	(10,397		)	(10,691		)
FFO applicable to common shares	327,650			293,621			667,178			558,423
Distributions on dilutive convertible units	3,336			3,127			6,664			6,249
Diluted FFO applicable to common shares	$	330,986		$	296,748		$	673,842		$	564,672

Diluted FFO per common share	$	0.72		$	0.69		$	1.46		$	1.34

Weighted average shares used to calculate diluted FFO per common share	461,435			427,496			461,045			422,507

Impact of adjustments to FFO:
Preferred stock redemption charge(1)	$	—		$	—		$	—		$	10,432

Table of Contents

	Three Months Ended June 30,				Six Months Ended June 30,
	2013		2012		2013		2012
FFO as adjusted applicable to common shares	$	327,650	$	293,621	$	667,178	$	568,855
Distributions on dilutive convertible units and other	3,336		3,127		6,664		6,218
Diluted FFO as adjusted applicable to common shares	$	330,986	$	296,748	$	673,842	$	575,073

Diluted FFO as adjusted per common share	$	0.72	$	0.69	$	1.46	$	1.36

Weighted average shares used to calculate diluted FFO as adjusted per common share	461,435		427,496		461,045		422,507

(1) In connection with the redemption of our preferred stock, during the three months ended March 31, 2012, we incurred a redemption charge of $10.4 million related to the original issuance costs.

Off-Balance Sheet Arrangements

We own interests in certain unconsolidated joint ventures as described under Note 7 to the Condensed Consolidated Financial Statements. Except in limited circumstances, our risk of loss is limited to our investment in the joint venture and any outstanding loans receivable. In addition, we have certain properties which serve as collateral for debt that is owed by a previous owner of certain of our facilities, as described under Note 11 to the Condensed Consolidated Financial Statements. Our risk of loss for these certain properties is limited to the outstanding debt balance plus penalties, if any. We have no other material off-balance sheet arrangements that we expect would materially affect our liquidity and capital resources except those described below under “Contractual Obligations.”

Contractual Obligations

The following table summarizes our material contractual payment obligations and commitments at June 30, 2013 (in thousands):

	Total(1)		Less than One Year		2014-2015		2016-2017		More than Five Years
Line of credit(2)	$	261,582	$	—	$	—	$	261,582	$	—
Term loan(3)	208,418		—		—		208,418		—
Senior unsecured notes	6,587,000		400,000		887,000		1,650,000		3,650,000
Mortgage debt	1,660,002		254,973		488,832		842,729		73,468
Construction loan commitments(4)	45,672		15,849		29,823		—		—
Development commitments(5)	26,842		26,675		167		—		—
Ground and other operating leases	217,699		3,506		11,364		7,807		195,022
Interest(6)	2,356,371		213,521		726,099		528,615		888,136
Total	$	11,363,586	$	914,524	$	2,143,285	$	3,499,151	$	4,806,626

(1) Excludes $79 million of other debt that represents Life Care Bonds that have no scheduled maturities.

(2) Includes £109 million translated into U.S. dollars.

(3) Represents £137 million translated into U.S. dollars.

(4) Represents commitments to finance development projects and related working capital financings.

(5) Represents construction and other commitments for developments in progress.

(6) Interest on variable-rate debt is calculated using rates in effect at June 30, 2013.

Inflation

Our leases often provide for either fixed increases in base rents or indexed escalators, based on the Consumer Price Index or other measures, and/or additional rent based on increases in the tenants’ operating revenues. Most of our MOB leases require the tenant to pay a share of property operating costs such as real estate taxes, insurance and utilities. Substantially all of our senior housing, life science, post-acute/skilled nursing and hospital leases require the operator or tenant to pay all of the property operating costs or reimburse us for all such costs. We believe that inflationary increases in expenses will be offset, in part, by the operator or tenant expense reimbursements and contractual rent increases described above.

Table of Contents

Recent Accounting Pronouncements

See Note 2 to the Condensed Consolidated Financial Statements for the impact of new accounting standards. There are no accounting pronouncements that have been issued, but not yet adopted by us, that we believe will materially impact our condensed consolidated financial statements.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We use derivative financial instruments in the normal course of business to mitigate interest rate and foreign currency risk. We do not use derivative financial instruments for speculative or trading purposes. Derivatives are recorded on the condensed consolidated balance sheets at their fair value. See Note 19 to the Condensed Consolidated Financial Statements for additional information.

To illustrate the effect of movements in the interest rate and foreign currency markets, we performed a market sensitivity analysis on our hedging instruments. We applied various basis point spreads to the underlying interest rate curves and foreign currency exchange rates of the derivative portfolio in order to determine the instruments’ change in fair value. Assuming a one percentage point change in the underlying interest rate curve and foreign currency exchange rates, the estimated change in fair value of each of the underlying derivative instruments would not exceed $7 million. See Note 19 to the Condensed Consolidated Financial Statements for additional analysis details.

Interest Rate Risk. At June 30, 2013, we were exposed to market risks related to fluctuations in interest rates on properties with a gross value of $83 million that are subject to leases where the payments fluctuate with changes in LIBOR and $165 million (£108 million) of loans receivable (see additional discussion of the Barchester loan in Note 6 to the Condensed Consolidated Financial Statements). Our exposure to income fluctuations related to our variable-rate investments is partially offset by: (i) $25 million of variable-rate senior unsecured notes; (ii) $15 million of variable-rate mortgage debt payable (excludes $86 million of variable-rate mortgage notes that have been hedged through interest-rate swap contracts); and (iii) $262 million (includes £109 million) of variable-rate line of credit borrowings. Additionally, our exposure to market risks related to fluctuations in interest rates excludes our GBP denominated $208 million (£137 million) variable-rate Term Loan that has been hedged through interest-rate swap contracts.

Interest rate fluctuations will generally not affect our future earnings or cash flows on our fixed rate debt and assets unless such instruments mature or are otherwise terminated. However, interest rate changes will affect the fair value of our fixed rate instruments. Conversely, changes in interest rates on variable rate debt and investments would change our future earnings and cash flows, but not significantly affect the fair value of those instruments. Assuming a one percentage point increase in the interest rate related to the variable-rate investments and variable-rate debt, and assuming no other changes in the outstanding balance as of June 30, 2013, our annual interest expense would increase by approximately $0.5 million, or less than $0.01 per common share on a diluted basis.

Foreign Currency Risk. At June 30, 2013, our exposure to foreign currency exchange rates relates to forecasted interest receipts from our GBP denominated senior unsecured notes (see additional discussion of the Four Seasons senior unsecured notes in Note 9 to the Condensed Consolidated Financial Statements) and our GBP denominated loan receivable (see additional discussion of the Barchester loan in Note 6 to the Condensed Consolidated Financial Statements). Our foreign currency exchange exposure is mitigated by the forecasted interest and principal payments from our GBP denominated unsecured Term Loan and the portion of our Facility denominated in GBP (see Note 10 to the Condensed Consolidated Financial Statements for additional information), and a foreign currency swap contract for approximately 85% of the forecasted interest receipts from our Four Seasons senior unsecured notes through their non-call period, which ends on June 15, 2016.

Market Risk. We have investments in marketable debt securities classified as held-to-maturity, because we have the positive intent and ability to hold the securities to maturity. Held-to-maturity securities are recorded at amortized cost and adjusted for the amortization of premiums and discounts through maturity. We consider a variety of factors in evaluating an other-than-temporary decline in value, such as: the length of time and the extent to which the market value has been less than our current adjusted carrying value; the issuer’s financial condition, capital strength and near-term prospects; any recent events specific to that issuer and economic conditions of its industry; and our investment horizon in relationship to an anticipated near-term recovery in the market value, if any. At June 30, 2013, the fair value and adjusted carrying value of marketable debt securities were $256 million and $225 million, respectively.

Table of Contents

Item 4. Controls and Procedures

Disclosure Controls and Procedures. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), to allow for timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Also, we have investments in certain unconsolidated entities. Our disclosure controls and procedures with respect to such entities are substantially more limited than those we maintain with respect to our consolidated subsidiaries.

As required by Rules 13a-15(b) and 15d-15(b) of the Securities Exchange Act of 1934, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2013. Based upon that evaluation, our Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer) concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Securities Exchange Act of 1934) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1A. Risk Factors

There are no material changes to the risk factors previously disclosed in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2012.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

(a)

On May 24, 2013, we issued 12,256 shares of our common stock upon the redemption of 6,128 non-managing member units of our subsidiary, HCPI/Utah II LLC (“HCPI/Utah II”), to a non-managing member of HCPI/Utah II. The shares of our common stock were issued in a private placement to an accredited investor pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. We did not receive any cash proceeds from the issuance of shares of our common stock to the non-managing member upon redemption of the units, although we did acquire non-managing member units of HCPI/Utah II in exchange for the shares of common stock we issued to the non-managing member.

(b)

None.

(c)

The table below sets forth information with respect to purchases of our common stock made by us or on our behalf or by any “affiliated purchaser,” as such term is defined in Rule 10b-18(a)(3) of the Securities Exchange Act of 1934, as amended, during the three months ended June 30, 2013.

Period Covered	Total Number Of Shares Purchased(1)	Average Price Paid Per Share		Total Number Of Shares (Or Units) Purchased As Part Of Publicly Announced Plans Or Programs	Maximum Number (Or Approximate Dollar Value) Of Shares (Or Units) That May Yet Be Purchased Under The Plans Or Programs
April 1-30, 2013	1,747	$	52.76	—	—
May 1-31, 2013	30,012	49.62		—	—
Total	31,759	49.79		—	—

(1) Represents restricted shares withheld under our 2006 Performance Incentive Plan (the “2006 Incentive Plan”), to offset tax withholding obligations that occur upon vesting of restricted shares. Our 2006 Incentive Plan provides that the value of the shares withheld shall be the closing price of our common stock on the date the relevant transaction occurs.

Table of Contents

Item 6. Exhibits

2.2		Purchase and Sale Agreement, dated as of October 16, 2012, by and among BRE/SW Portfolio LLC, those owner entities listed on Schedule 1 thereto, HCP, Inc. and Emeritus Corporation; and First Amendment to such Purchase and Sale Agreement, by and among such parties, dated as of December 4, 2012 (incorporated by reference to Exhibit 2.2 to HCP’s Quarterly Report on Form 10-Q (File No. 1-08895) filed May 2, 2013).

3.1		Articles of Restatement of HCP (incorporated by reference to Exhibit 3.1 to HCP’s Registration Statement on Form S-3 (Registration No. 333-182824), filed on July 24, 2012).

3.2		Fourth Amended and Restated Bylaws of HCP (incorporated herein by reference to Exhibit 3.1 to HCP’s Current Report on Form 8-K (File No. 1-08895) filed September 25, 2006).

10.1		Amendment No. 1, dated as of April 5, 2013, to the Employment Agreement, dated as of January 26, 2012, by and between the Company and Paul F. Gallagher (incorporated herein by reference to Exhibit 10.1 to HCP’s Current Report on Form 8-K (File No. 1-08895) filed April 5, 2013). †

10.2		Amendment No. 1, dated as of April 5, 2013, to the Employment Agreement, dated as of January 26, 2012, by and between the Company and Timothy M. Schoen (incorporated herein by reference to Exhibit 10.2 to HCP’s Current Report on Form 8-K (File No. 1-08895) filed April 5, 2013). †

10.3		Amendment No. 1, dated as of April 5, 2013, to the Employment Agreement, dated October 25, 2012, by and between the Company and James W. Mercer (incorporated herein by reference to Exhibit 10.3 to HCP’s Current Report on Form 8-K (File No. 1-08895) filed April 5, 2013). †

10.4		Amendment No. 2 to Credit Agreement, dated May 7, 2013, by and among the Company, as borrower, the financial institutions referred to therein, and Bank of America, N.A., as administrative agent.

31.1		Certification by James F. Flaherty III, HCP’s Principal Executive Officer, Pursuant to Securities Exchange Act Rule 13a-14(a). *

31.2		Certification by Timothy M. Schoen, HCP’s Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a-14(a). *

32.1		Certification by James F. Flaherty III, HCP’s Principal Executive Officer, Pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350. **

32.2		Certification by Timothy M. Schoen, HCP’s Principal Financial Officer, Pursuant to Securities Exchange Act Rule 13a-14(b) and 18 U.S.C. Section 1350. **

101.INS		XBRL Instance Document.*

101.SCH		XBRL Taxonomy Extension Schema Document.*

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document.*

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document.*

101.LAB		XBRL Taxonomy Extension Labels Linkbase Document.*

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document.*

*	Filed herewith.
**	Furnished herewith.
†	Management Contract or Compensatory Plan or Arrangement.

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: August 2, 2013	HCP, Inc.

	(Registrant)

	/s/ JAMES F. FLAHERTY III
	James F. Flaherty III
	Chairman and Chief Executive Officer
	(Principal Executive Officer)


	/s/ TIMOTHY M. SCHOEN
	Timothy M. Schoen
	Executive Vice President-
	Chief Financial Officer
	(Principal Financial Officer)


	/s/ SCOTT A. ANDERSON
	Scott A. Anderson
	Senior Vice President-
	Chief Accounting Officer
	(Principal Accounting Officer)